<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">26747</article-id><article-id pub-id-type="doi">10.7554/eLife.26747</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>Tumor-promoting function of apoptotic caspases by an amplification loop involving ROS, macrophages and JNK in <italic>Drosophila</italic></article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-85155"><name><surname>Pérez</surname><given-names>Ernesto</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">‡</xref></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-85156"><name><surname>Lindblad</surname><given-names>Jillian L</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-2607"><name><surname>Bergmann</surname><given-names>Andreas</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9134-871X</contrib-id><email>andreas.bergmann@umassmed.edu</email><xref ref-type="aff" rid="aff1"/><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Molecular, Cell and Cancer Biology</institution><institution>University of Massachusetts Medical School</institution><addr-line><named-content content-type="city">Worcester</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1140"><name><surname>McNeill</surname><given-names>Helen</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto</institution><country>Canada</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Biology, Austin College, Sherman, United States</p></fn><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="update" publication-format="electronic"><month>09</month><day>20</day><year>2017</year></pub-date><pub-date date-type="publication" publication-format="electronic"><day>30</day><month>08</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e26747</elocation-id><history><date date-type="received" iso-8601-date="2017-03-13"><day>13</day><month>03</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-08-28"><day>28</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Pérez et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Pérez et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-26747-v2.pdf"/><related-object ext-link-type="url" xlink:href="https://elifesciences.org/articles/e26747v1"><date date-type="v1" iso-8601-date="2017-08-30"><day>30</day><month>08</month><year>2017</year></date></related-object><related-object ext-link-type="url" xlink:href="https://elifesciences.org/articles/e26747v2"><date date-type="v2" iso-8601-date="2017-09-20"><day>20</day><month>09</month><year>2017</year></date></related-object><abstract><object-id pub-id-type="doi">10.7554/eLife.26747.001</object-id><p>Apoptosis and its molecular mediators, the caspases, have long been regarded as tumor suppressors and one hallmark of cancer is ‘Evading Apoptosis’. However, recent work has suggested that apoptotic caspases can also promote proliferation and tumor growth under certain conditions. How caspases promote proliferation and how cells are protected from the potentially harmful action of apoptotic caspases is largely unknown. Here, we show that although caspases are activated in a well-studied neoplastic tumor model in <italic>Drosophila</italic>, oncogenic mutations of the proto-oncogene Ras (<italic>Ras<sup>V12</sup></italic>) maintain tumorous cells in an ‘undead’-like condition and transform caspases from tumor suppressors into tumor promotors. Instead of killing cells, caspases now promote the generation of intra- and extracellular reactive oxygen species (ROS). One function of the ROS is the recruitment and activation of macrophage-like immune cells which in turn signal back to tumorous epithelial cells to activate oncogenic JNK signaling. JNK further promotes and amplifies caspase activity, thereby constituting a feedback amplification loop. Interfering with the amplification loop strongly reduces the neoplastic behavior of these cells and significantly improves organismal survival. In conclusion, <italic>Ras<sup>V12</sup></italic>-modified caspases initiate a feedback amplification loop involving tumorous epithelial cells and macrophage-like immune cells that is necessary for uncontrolled tumor growth and invasive behavior.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.26747.002</object-id><title>eLife digest</title><p>Throughout the development and life of an animal, many of its cells die and are removed to make space for new tissues. A group of proteins called caspases play a key role in this cell death process. Chemotherapy and radiotherapy work as cancer treatments because they damage dividing cancer cells to such an extent that caspases are turned on and kill those cells. Unfortunately the tumor occasionally grows back after the treatment, partly because caspases also help to produce signals that boost the growth of any surviving cancer cells.</p><p>Pérez, Lindblad and Bergmann have now used the fruit fly <italic>Drosophila</italic> to investigate how caspases encourage tumor cells to grow and spread. The fruit flies all carried a mutation in a gene called <italic>Ras</italic>, which is often mutated in human cancers. Using a combination of genetic and biochemical experiments Pérez, Lindblad and Bergmann found that mutant <italic>Ras</italic> prevents cells with active caspases from dying. Instead, the caspases redirect their activity and help cancer cells to produce small chemicals called reactive oxygen species. These chemicals can play many different roles in cancers, but in this setting they attract immune cells to the site of the tumor. The immune cells in turn send other signals back to the cancer cells, which further activate the caspases. Overall, this self-perpetuating signaling loop between the cancer cells and the surrounding immune cells helps the tumors to grow.</p><p>Future work toward developing new cancer treatments will need to work on ways of enhancing the cell-killing properties of caspases while inhibiting their ability to help tumors to grow. Further experiments will also be needed to find out exactly how the mutant <italic>Ras</italic> gene protects tumor cells from death.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>caspase</kwd><kwd>apoptosis</kwd><kwd>Reactive oxygen species</kwd><kwd>Scrib</kwd><kwd>oncogenic ras</kwd><kwd>hemocyte</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>D. melanogaster</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM118330</award-id><principal-award-recipient><name><surname>Bergmann</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R01GM107789</award-id><principal-award-recipient><name><surname>Bergmann</surname><given-names>Andreas</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The oncogenic <italic>Ras<sup>V12</sup></italic> keeps cells mutant for the tumor suppressor scribble in an undead-like condition, which is required for an amplification loop that promotes tumorigenesis.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Larval imaginal discs in <italic>Drosophila</italic> are single-cell layered sacs of epithelial cells that develop into the adult appendages such as eyes and wings, and are frequently used as genetic models for growth control and tumor development. Maintenance of apical-basal polarity of epithelial cells is critical for suppression of neoplastic tumor development (<xref ref-type="bibr" rid="bib22">Elsum et al., 2012</xref>; <xref ref-type="bibr" rid="bib7">Bergstralh and St Johnston, 2012</xref>; <xref ref-type="bibr" rid="bib60">Martin-Belmonte and Perez-Moreno, 2011</xref>). Mutations in genes encoding components of the Scribble complex including <italic>scribble</italic> (<italic>scrib</italic>), <italic>lethal giant larvae</italic> (<italic>lgl</italic>) and <italic>discs large</italic> (<italic>dlg</italic>) disrupt apical-basal polarity in epithelial cells which can trigger malignant neoplastic tumor growth (<xref ref-type="bibr" rid="bib7">Bergstralh and St Johnston, 2012</xref>; <xref ref-type="bibr" rid="bib22">Elsum et al., 2012</xref>; <xref ref-type="bibr" rid="bib8">Bilder et al., 2000</xref>; <xref ref-type="bibr" rid="bib32">Gateff, 1978</xref>; <xref ref-type="bibr" rid="bib9">Bilder and Perrimon, 2000</xref>). <italic>Drosophila</italic> larvae entirely mutant for <italic>scrib</italic> fail to respond to stop signals of growth, fail to pupariate and continue to grow as larvae (<xref ref-type="bibr" rid="bib33">Gateff, 1994</xref>; <xref ref-type="bibr" rid="bib93">Wodarz, 2000</xref>). They die as giant larvae with severely overgrown imaginal discs.</p><p>However, <italic>scrib</italic> mutant cells (clones) in otherwise wild-type imaginal discs are eliminated by cell competition mediated by neighboring wild-type cells (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib63">Menéndez et al., 2010</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib69">Ohsawa et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Leong et al., 2009</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="bib90">Vaughen and Igaki, 2016</xref>). Mechanistically, in response to cell competition, Eiger, the Tumor Necrosis Factor alpha (TNFα)-like ligand in <italic>Drosophila</italic>, triggers Jun N-terminal kinase (JNK) activation and apoptosis in <italic>scrib</italic> mutant cells (<xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib69">Ohsawa et al., 2011</xref>; <xref ref-type="bibr" rid="bib56">Leong et al., 2009</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>). This tumor-suppressing function is dependent on Eiger and JNK through induction of apoptosis. Inhibition of Eiger or JNK restores the growth potential of <italic>scrib</italic> mutant cells which can then form large tumor masses in imaginal discs (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>).</p><p>However, if additional oncogenic mutations such as <italic>Ras<sup>V12</sup></italic> are introduced into <italic>scrib</italic> mutant cells (referred to a <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic>), they can unleash their full malignant potential (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib71">Pagliarini and Xu, 2003</xref>). <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye/antennal imaginal discs display all neoplastic features observed in human tumors including unrestricted growth, failure to differentiate, tissue invasion and organismal lethality (<xref ref-type="bibr" rid="bib71">Pagliarini and Xu, 2003</xref>; <xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>). <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones occupy a large portion of the mosaic disc and trigger multi-layered overgrowth of the entire disc compared to wild-type controls (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>). <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells also invade other tissues, most notably the ventral nerve cord (VNC) in the brain (<xref ref-type="fig" rid="fig1">Figure 1H,I</xref>) (<xref ref-type="bibr" rid="bib71">Pagliarini and Xu, 2003</xref>). The <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> condition in <italic>ey-FLP</italic>-induced eye imaginal disc mosaics is 100% lethal. 95% of <italic>ey-FLP</italic>-induced <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic animals die as larvae; the remaining animals die during pupal stages.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.003</object-id><label>Figure 1.</label><caption><title>Both intra- and extracellular ROS contribute to the strong neoplastic phenotype of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic>.</title><p>Mosaic animals in this and subsequent figures were obtained using the MARCM technique (<xref ref-type="bibr" rid="bib55">Lee and Luo, 1999</xref>) with <italic>ey-FLP</italic> (<xref ref-type="bibr" rid="bib68">Newsome et al., 2000</xref>) to induce mitotic recombination in eye imaginal discs. GFP depicts MARCM clones. Posterior is to the right. (<bold>A–D’</bold>) Wild-type (wt, <italic>FRT +</italic>) (<bold>A</bold>), <italic>scribble</italic> (<italic>scrib</italic><sup>−/−</sup>) (<bold>B</bold>), <italic>Ras<sup>V12</sup></italic>–expressing (<bold>C</bold>) and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>D</bold>) eye/antennal mosaic imaginal discs from third instar larvae labeled with the ROS indicator Dihydroethidium (DHE). Scale bars: 50 μm. (<bold>E</bold>) Enlarged <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones labeled for DHE. Arrowhead in (<bold>E’</bold>) marks a cell of high DHE labeling. (<bold>F</bold>) DHE quantification reveals that ROS levels are significantly higher in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones compared to wt (<italic>FRT</italic> +), <italic>scrib</italic><sup>−/−</sup> or <italic>Ras<sup>V12</sup></italic>-expressing clones. Plotted is the mean signal intensity ±SD of DHE labelings in clones, analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p&lt;0.0001; ns – not significant. Multiple clones from five to ten discs of each genotype were analyzed. (<bold>G</bold>) Reduction of extra- and intracellular ROS levels in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones significantly improves the pupariation rates of animals bearing <italic>scrib Ras<sup>V12</sup></italic> mosaic eye imaginal discs. Expression of <italic>UAS-lacZ</italic> in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones as control has no effect on the pupariation rate. Pupariation rates were determined as the ratio of late stage mutant pupae vs total pupae and were analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are relative to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> results (left column) and are indicated above the experimental columns. ****p&lt;0.0001; ns – not significant. At least 100 pupae were counted per genotype. Experiments were performed three times. (<bold>H–N</bold>) Cephalic complexes composed of eye/antennal discs, optic lobes (OL) and ventral nerve cord (VNC) from day 11 old third instar larvae. The genotype is indicated on top of each panel. Expression of <italic>UAS-lacZ</italic> served as negative control (<bold>I</bold>). Depletion of ROS strongly reduces clone size (green) and normalizes growth in (<bold>J–N</bold>). DAPI (blue) labels the outline of the tissue. Scale bars: 200 μm. (<bold>O–U</bold>) Adult eyes of control (<bold>O</bold>) and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaics expressing the indicated antioxidant transgenes (<bold>Q–U</bold>). The percentage number in the top right of each panel indicates the adult survival rate relative to pupal survival. Note that <italic>ey-FLP</italic>-induced <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> MARCM mosaics are 100% lethal (0% adult survival) (<bold>P</bold>). <bold>Genotypes</bold>: (<bold>A,H,O</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/. <italic>FRT82B w</italic><sup>+</sup>; (<bold>B</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/. <italic>FRT82B scrib<sup>2</sup></italic>; (<bold>C</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-Ras<sup>V12</sup>; FRT82B tub-Gal80</italic>/<italic>FRT82B w</italic><sup>+</sup>; (<bold>D,E,P</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>I–N,Q–U</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-lacZ</italic> (<bold>I</bold>), <italic>UAS-Duox</italic><sup>RNAi</sup> (<bold>J,Q</bold>), <italic>UAS-hCatS</italic> (<bold>K,R</bold>), <italic>UAS-Catalase</italic> (<bold>L,S</bold>), <italic>UAS-SOD1</italic> (<bold>M,T</bold>) and <italic>UAS-SOD2</italic> (<bold>N,U</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26747.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>Caspase-dependent generation of ROS as revealed by H<sub>2</sub>DCF-DA labelings.</title><p>Mosaic eye-antennal imaginal discs in this figure were obtained using a modified MARCM technique with <italic>ey-FLP</italic> in which clones are marked by myrRFP (red) (<xref ref-type="bibr" rid="bib12">Chabu and Xu, 2014</xref>). Posterior is to the right. Scale bars: 50 μm. (<bold>A–F’’</bold>) Wild-type (wt, <italic>FRT +</italic>) (<bold>A</bold>), <italic>Ras<sup>V12</sup></italic>–expressing (<bold>B</bold>), <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>C</bold>) and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> eye/antennal mosaic imaginal discs expressing <italic>dronc</italic> RNAi (<bold>D</bold>), <italic>drICE</italic> RNAi (<bold>E</bold>) and <italic>p35</italic> (<bold>F</bold>) from third instar larvae were labeled with the ROS indicator H<sub>2</sub>DCF-CA (green). The (‘) panels show the H<sub>2</sub>DCF-CA-only channel, the (‘‘) show RFP-only. There is strong increase of H<sub>2</sub>DCF-CA labeling in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones in a caspase-dependent manner. (<bold>G</bold>) Quantification of H<sub>2</sub>DCF-CA labelings revealed that ROS levels are significantly higher in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones (<bold>C</bold>) compared to wt (<italic>FRT</italic> +) (<bold>A</bold>) and <italic>Ras<sup>V12</sup></italic> (<bold>B</bold>) clones. Loss of caspase activity also significantly reduces H<sub>2</sub>DCF-CA labelings (<bold>D–F</bold>). Shown is the mean signal intensity ±SD of H<sub>2</sub>DCF-CA labelings, analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. P values are relative to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> results (third column) and are indicated above the experimental columns. ***p&lt;0.001; **p&lt;0.01. Ten discs of each genotype were analyzed. <bold>Genotypes</bold>: (<bold>A</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-myrRFP</italic>/+; <italic>FRT82B tub-Gal80</italic>/. <italic>FRT82B w</italic><sup>+</sup>; (<bold>B</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-myrRFP</italic>/<italic>UAS-Ras<sup>V12</sup>; FRT82B tub-Gal80</italic>/<italic>FRT82B w</italic><sup>+</sup>; (<bold>C</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-myrRFP</italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>D–F</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-myrRFP</italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-dronc</italic><sup>RNAi</sup> (<bold>D</bold>), <italic>UAS-drICE</italic><sup>RNAi</sup> (<bold>E</bold>) and <italic>UAS-p35</italic> (<bold>F</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26747.005</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Strong induction of β-Gal by expression of <italic>UAS-lacZ</italic> in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones.</title><p>(<bold>A,A’</bold>) Strong expression of a <italic>UAS-lacZ</italic> transgene in mosaic <italic>scrib Ras<sup>V12</sup></italic> eye imaginal discs as revealed by anti β-Gal labeling (red in (<bold>A</bold>); grey in (<bold>A’</bold>)). Scale bar: 100 μm. Genotype: (<bold>A</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-lacZ; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig1-figsupp2-v2"/></fig></fig-group><p>Interestingly, Ras<sup>V12</sup> inhibits the apoptotic activity of JNK and converts the tumor-suppressor function of Eiger and JNK in <italic>scrib</italic><sup>−/−</sup> cells into a tumor-promoting one in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells (<xref ref-type="bibr" rid="bib23">Enomoto et al., 2015</xref>; <xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib89">Uhlirova and Bohmann, 2006</xref>). Therefore, the aggressive tumor growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones becomes dependent on Eiger and JNK (<xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib89">Uhlirova and Bohmann, 2006</xref>; <xref ref-type="bibr" rid="bib11">Brumby et al., 2011</xref>). Mechanistically, it is not understood how Ras<sup>V12</sup> promotes this oncogenic switch of Eiger and JNK.</p><p>Caspases are Cys-proteases that mediate the mechanistic events of apoptotic cell death (<xref ref-type="bibr" rid="bib84">Shalini et al., 2015</xref>; <xref ref-type="bibr" rid="bib95">Xu et al., 2009</xref>; <xref ref-type="bibr" rid="bib31">Fuchs and Steller, 2011</xref>; <xref ref-type="bibr" rid="bib81">Salvesen et al., 2016</xref>). They are synthesized as zymogens and depending on the length of their prodomains can be classified into initiator and effector caspases. Initiator caspases such as mammalian Caspase-9 or its <italic>Drosophila</italic> ortholog Dronc are controlled by upstream signaling events and when activated initiate apoptosis by activating effector caspases such as mammalian Caspase-3 or its <italic>Drosophila</italic> ortholog DrICE (<xref ref-type="bibr" rid="bib31">Fuchs and Steller, 2011</xref>; <xref ref-type="bibr" rid="bib84">Shalini et al., 2015</xref>; <xref ref-type="bibr" rid="bib81">Salvesen et al., 2016</xref>). Caspases induce apoptosis of many cells to maintain homeostatic conditions, and are also thought to be critical for tumor suppression by eliminating malignant cells.</p><p>However, caspases can also have tumor-promoting roles, for example through apoptosis-induced proliferation (AiP), a caspase-driven process by which apoptotic cells produce mitogenic signals for proliferation of neighboring surviving cells (<xref ref-type="bibr" rid="bib64">Mollereau et al., 2013</xref>) (reviewed in [<xref ref-type="bibr" rid="bib30">Fogarty and Bergmann, 2017</xref>; <xref ref-type="bibr" rid="bib80">Ryoo and Bergmann, 2012</xref>]). There are two types of AiP. During ‘genuine’ AiP, apoptotic cells release mitogenic factors before completing the apoptotic program. This type of AiP has been described for regeneration and wound healing both in vertebrates and invertebrates (<xref ref-type="bibr" rid="bib87">Tseng et al., 2007</xref>; <xref ref-type="bibr" rid="bib24">Fan and Bergmann, 2008</xref>; <xref ref-type="bibr" rid="bib16">Chera et al., 2009</xref>; <xref ref-type="bibr" rid="bib58">Li et al., 2010</xref>). ‘Genuine’ AiP may also be involved in human pathologies such as cancer, and may account for increased cell proliferation and repopulation of tumors following cytotoxic treatments (chemo- or radiotherapy) which induces massive apoptosis (reviewed in [<xref ref-type="bibr" rid="bib30">Fogarty and Bergmann, 2017</xref>; <xref ref-type="bibr" rid="bib45">Ichim and Tait, 2016</xref>]). Caspases play significant tumor-promoting roles in these settings (<xref ref-type="bibr" rid="bib58">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib43">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="bib21">Donato et al., 2014</xref>; <xref ref-type="bibr" rid="bib15">Cheng et al., 2015</xref>; <xref ref-type="bibr" rid="bib96">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib51">Kurtova et al., 2015</xref>).</p><p>The second type is ‘undead’ AiP. Here, the apoptosis pathway is induced upstream, but the execution of apoptosis is blocked. In <italic>Drosophila</italic>, apoptosis inhibition is achieved experimentally by expression of the effector caspase inhibitor p35 which very specifically inhibits DrICE (<xref ref-type="bibr" rid="bib40">Hay et al., 1994</xref>; <xref ref-type="bibr" rid="bib62">Meier et al., 2000</xref>; <xref ref-type="bibr" rid="bib39">Hawkins et al., 2000</xref>). Therefore, because these cells have initiated the apoptotic process and contain active Dronc, but cannot die, they are referred to as ‘undead’. In ‘undead’ cells, non-apoptotic functions of active Dronc can now be examined, one of which is the release of mitogenic signals for induction of AiP which can lead to hyperplastic overgrowth (<xref ref-type="bibr" rid="bib92">Wells et al., 2006</xref>; <xref ref-type="bibr" rid="bib49">Kondo et al., 2006</xref>; <xref ref-type="bibr" rid="bib44">Huh et al., 2004</xref>; <xref ref-type="bibr" rid="bib79">Ryoo et al., 2004</xref>; <xref ref-type="bibr" rid="bib61">Martín et al., 2009</xref>; <xref ref-type="bibr" rid="bib77">Pérez-Garijo et al., 2009</xref>; <xref ref-type="bibr" rid="bib75">Pérez-Garijo et al., 2004</xref>; <xref ref-type="bibr" rid="bib27">Fan et al., 2014</xref>; <xref ref-type="bibr" rid="bib78">Rudrapatna et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Pérez-Garijo et al., 2005</xref>). ‘Undead’ states of cells may also be present under pathological conditions. For instance, it has been proposed that <italic>Ras<sup>V12</sup></italic> can maintain apoptotic cells in an ‘undead’-like state promoting tumorigenesis (<xref ref-type="bibr" rid="bib41">Hirabayashi et al., 2013</xref>).</p><p>Mechanistically, we have shown that AiP-mediated hyperplastic overgrowth of ‘undead’ tissue depends on a Dronc-initiated feedback amplification loop which involves reactive oxygen species (ROS) – specifically extracellular ROS produced by the membrane-bound NADPH oxidase Duox –, activation of macrophage-like hemocytes, secretion of Eiger by hemocytes, Eiger-dependent activation of JNK in epithelial disc and further activation of Dronc by JNK (<xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>) (reviewed by [<xref ref-type="bibr" rid="bib19">Diwanji and Bergmann, 2017a</xref>; <xref ref-type="bibr" rid="bib20">Diwanji and Bergmann, 2017b</xref>]). Therefore, similar to the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> case, Eiger and JNK signaling have proliferation- and growth-promoting functions in this ‘undead’ AiP model.</p><p>These similarities prompted us to investigate the role of ROS and caspases for tumor growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones in <italic>Drosophila</italic>. We report that oncogenic Ras switches the pro-apoptotic activity of caspases into a tumor-promoting one and thereby maintains <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells in an ‘undead’-like state. Consistently, inhibition of caspases blocks tumor growth and tissue invasion. The tumor-promoting function of apoptotic caspases is dependent on the generation of intra- and extracellular ROS which are required for neoplastic behavior of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones. Furthermore, caspase-induced ROS are essential for the recruitment and activation of hemocytes at <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs. Hemocytes signal back to tumorous epithelial cells to stimulate JNK signaling which further promotes caspase activity. Thus, these events constitute a feedback amplification loop which is necessary for neoplastic activity of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells. This work extends previous models about the conversion of Eiger and JNK signaling from anti-tumor to pro-tumor roles by oncogenic Ras and identifies caspases as essential components of this switch. In conclusion, although apoptotic caspases are usually considered to be tumor suppressors, under certain conditions, for example in the presence of oncogenic <italic>Ras<sup>V12</sup></italic> in <italic>scrib</italic> mutant cells, they can also adopt a tumor-promoting role.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>ROS are required for neoplastic characteristics of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs</title><p>Recently, in a model of ‘undead’ AiP, we showed that Duox-generated ROS are important for activation of hemocytes, JNK signaling and hyperplastic overgrowth (<xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>; <xref ref-type="bibr" rid="bib19">Diwanji and Bergmann, 2017a</xref>; <xref ref-type="bibr" rid="bib20">Diwanji and Bergmann, 2017b</xref>). Therefore, we examined if ROS have a similar function in the neoplastic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumor model in <italic>Drosophila. scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones were induced by MARCM using <italic>ey-FLP</italic> in eye/antennal imaginal discs, the traditional tissue for this model (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib71">Pagliarini and Xu, 2003</xref>). The ROS indicator dihydroethidium (DHE) strongly labels <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones in mosaic discs, while wild-type (wt), <italic>scrib</italic><sup>−/−</sup> and <italic>Ras<sup>V12</sup></italic>-expressing clones are not labeled by DHE or very little (<xref ref-type="fig" rid="fig1">Figure 1A–D’</xref>; quantified in <xref ref-type="fig" rid="fig1">Figure 1F</xref>; see also <xref ref-type="fig" rid="fig2">Figure 2A,A’</xref>). Similar results were reported recently (<xref ref-type="bibr" rid="bib48">Katheder et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Manent et al., 2017</xref>). A different ROS indicator, H<sub>2</sub>DCF-DA, confirms these results (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–C,G</xref>). <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones display an increased diffuse cytosolic DHE labeling (<xref ref-type="fig" rid="fig1">Figure 1E,E’</xref>). At the boundary of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones, several cells stain very intensely for DHE (<xref ref-type="fig" rid="fig1">Figure 1E,E’</xref>; arrow head).</p><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.006</object-id><label>Figure 2.</label><caption><title>Caspases are required for ROS generation and neoplastic overgrowth in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic>.</title><p>(<bold>A–D’</bold>) Expression of the effector caspase inhibitor <italic>p35</italic> (<bold>B</bold>), <italic>drICE</italic> RNAi (<bold>C</bold>) and <italic>dronc</italic> RNAi (<bold>D</bold>) suppresses <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clone size (green) and ROS generation in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones. The (‘) panels indicate the labeling of the ROS indicator DHE (grey). Scale bars: 50 μm. (<bold>E</bold>) DHE quantification reveals that ROS levels are significantly reduced in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones with reduced or inhibited caspase activity. Shown is the mean signal intensity ±SD of DHE labelings in clones, analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p&lt;0.0001. Multiple clones from five to ten discs of each genotype were analyzed. (<bold>F–I</bold>) The growth and invasion of cephalic complexes of 11 day old <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> larvae (<bold>F</bold>) is strongly suppressed by p35 (<bold>G</bold>), <italic>drICE</italic> RNAi (<bold>H</bold>) and <italic>dronc</italic> RNAi (<bold>I</bold>). Clone size (green) in (<bold>F–I</bold>) is strongly reduced. DAPI labels the outline of the tissue. Scale bars: 200 μm. (<bold>J–M</bold>) Adult eyes of surviving <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> animals expressing <italic>p35</italic> (<bold>K</bold>), <italic>drICE</italic> RNAi (<bold>L</bold>) and <italic>dronc</italic> RNAi (<bold>M</bold>). The percentage number in the top right of each panel indicates the adult survival rate relative to pupal survival. (<bold>N</bold>) Reduction or inhibition of caspase activity in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones significantly improves the pupariation rates of animals bearing <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye imaginal discs. Pupariation rates were determined as the ratio of late stage mutant pupae vs total pupae and were analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are relative to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> results (left column) and are indicated above the experimental columns. ****p&lt;0.0001. At least 100 pupae were counted per genotype. Experiments were performed three times. <bold>Genotypes</bold>: (<bold>A,F,J</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>B–D,G–I,K–M</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-p35</italic> (<bold>B,G,K</bold>), <italic>UAS-drICE</italic><sup>RNAi</sup> (<bold>C,H,L</bold>) and <italic>UAS-dronc</italic><sup>RNAi</sup> (<bold>D,I,M</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig2-v2"/></fig><p>To examine the function of ROS in this neoplastic tumor model, we reduced their amount either by down-regulating ROS-producing enzymes such as Duox or by overexpressing ROS-removing enzymes such as catalases and superoxide dismutases (SOD). As shown previously, <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> occupy a large portion of the eye/antennal imaginal disc and display a strong neoplastic tumor phenotype (<xref ref-type="bibr" rid="bib71">Pagliarini and Xu, 2003</xref>) (see also <xref ref-type="fig" rid="fig2">Figure 2F</xref>). Because expression of the antioxidant enzymes was achieved by the UAS/Gal4 system, we tested first whether increasing the <italic>UAS</italic> gene dose may modify (suppress) the tumor phenotype and expressed an unrelated control gene, <italic>UAS-lacZ</italic>, in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones. However, despite strong expression of β-Gal (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>), the tumor phenotype of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> eye/antennal imaginal discs is not significantly suppressed by addition of an additional <italic>UAS</italic>-driven transgene (<xref ref-type="fig" rid="fig1">Figure 1I</xref>).</p><p>In contrast, removing extracellular ROS by <italic>UAS-Duox</italic> RNAi or overexpression of the <italic>UAS-hCatS</italic> transgene which encodes a secreted human catalase (<xref ref-type="bibr" rid="bib36">Ha et al., 2005b2005</xref>; <xref ref-type="bibr" rid="bib35">Ha et al., 2005a</xref>), strongly suppressed tumor growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells (<xref ref-type="fig" rid="fig1">Figure 1J,K</xref>) suggesting that extracellular ROS are required for tumor growth. Interestingly and in contrast to the ‘undead’ AiP model, removing intracellular ROS by misexpression of intracellular <italic>Catalase</italic>, <italic>SOD1</italic> and <italic>SOD2</italic> also strongly suppressed tumor growth (<xref ref-type="fig" rid="fig1">Figure 1L–N</xref>). These results suggest that both intra- and extracellular ROS are required for tumor growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones.</p><p>Importantly also, reduction of ROS strongly reduces the invasive behavior of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells (<xref ref-type="fig" rid="fig1">Figure 1J–N</xref>) which significantly improves the survival rate of the affected animals. Compared to <italic>ey</italic> &gt;MARCM <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant larvae, of which only 5% reach pupal stages, between 40% and 70% of the <italic>ey</italic> &gt;MARCM <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> larvae expressing antioxidant enzymes develop into pupae (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Expression of the <italic>UAS-lacZ</italic> control transgene does not improve pupal survival (<xref ref-type="fig" rid="fig1">Figure 1G</xref>). Furthermore, we also recovered viable adult <italic>ey</italic> &gt;MARCM <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic animals expressing antioxidant genes, although at a low rate (5–15% of the surviving pupae), which was never observed for <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> only (<xref ref-type="fig" rid="fig1">Figure 1P–U</xref>). Although their eyes and heads are deformed and weakly overgrown often with necrotic patches compared to wt control (<xref ref-type="fig" rid="fig1">Figure 1O,Q–U</xref>), these animals live! Previously, only few examples of surviving <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic animals have been reported. In these examples, viable <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic animals were recovered when essential steps in tumor development such as oncogenic JNK signaling or the cell cycle were inhibited in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib54">Külshammer et al., 2015</xref>; <xref ref-type="bibr" rid="bib53">Külshammer and Uhlirova, 2013</xref>). Therefore, the observation that reduction of ROS suppresses tumor growth and enhances organismal survival strongly suggests that ROS play a very significant role for the neoplastic characteristics of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> animals.</p></sec><sec id="s2-2"><title>Caspases promote tumors by inducing the generation of ROS</title><p>In ‘undead’ cells, the initiator caspase Dronc (caspase-9 ortholog) has been shown to stimulate the production of ROS (<xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>). Therefore, we examined the role of Dronc as well as the effector caspase DrICE (caspase-3 ortholog) for generation of ROS and tumorous overgrowth in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye discs. As an additional assay, we expressed the effector caspase inhibitor <italic>p35</italic> in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones. Removing or inhibiting caspases in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones strongly reduced DHE labeling suggesting suppression of ROS generation (<xref ref-type="fig" rid="fig2">Figure 2A–D’</xref>; quantified in <xref ref-type="fig" rid="fig2">Figure 2E</xref>). Similar results were obtained with a different ROS indicator, H<sub>2</sub>DCF-DA (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–G</xref>). Consequently, tumor overgrowth and invasion of the VNC is dramatically reduced upon removal or inhibition of caspases in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells (<xref ref-type="fig" rid="fig2">Figure 2F–I</xref>). Reduction of caspase activity also increases pupal survival (<xref ref-type="fig" rid="fig2">Figure 2N</xref>) and viable animals with mosaic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> heads and eyes were recovered as adults at a rate of 4–9% of the surviving pupae (<xref ref-type="fig" rid="fig2">Figure 2J–M</xref>).</p><p>The requirement of caspases for generation of ROS and neoplastic behavior suggests that caspases are activated in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells. To verify this, we labeled <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye discs with cleaved caspase-3 (CC3) antibody which detects activated (cleaved) effector caspases and an unknown non-apoptotic substrate of Dronc (<xref ref-type="bibr" rid="bib25">Fan and Bergmann, 2010</xref>; <xref ref-type="bibr" rid="bib86">Srinivasan et al., 1998</xref>). Indeed, while there is very little CC3 labeling in mosaic control discs (<italic>FRT +</italic>), <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones label significantly stronger with CC3 antibody (<xref ref-type="fig" rid="fig3">Figure 3A–B’</xref>, yellow arrowhead; quantified in <xref ref-type="fig" rid="fig3">Figure 3D</xref>). In addition to the CC3 labeling in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones, there is also staining immediately outside the clones which appears even more intense than the labeling inside the clones (<xref ref-type="fig" rid="fig3">Figure 3B,B’</xref>; white arrows). In fact, quantification reveals that this non-autonomous CC3 labeling is 2 to 2.5-fold higher than autonomous CC3 labeling in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). Both, CC3 labeling inside and outside of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones are autonomously dependent on the caspases DrICE (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) and Dronc as well as on ROS (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.007</object-id><label>Figure 3.</label><caption><title>Analysis of caspase activity and apoptosis in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye discs.</title><p>(<bold>A–C’</bold>) Cleaved caspase 3 (CC3) (red in (<bold>A–C</bold>); grey in (<bold>A’–C’</bold>)) analysis of control (wt, <italic>FRT +</italic>) (<bold>A</bold>), <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>B</bold>) and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> expressing <italic>drICE</italic> RNAi (<bold>C</bold>) mosaic eye imaginal discs. CC3 labeling is detectable autonomously (yellow arrowhead) and non-autonomously (white arrows) of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones (<bold>B’</bold>). Clones in (<bold>B’</bold>) and (<bold>C’</bold>) are outlined by yellow, dotted lines. Scale bars: 50 μm. (<bold>D</bold>) CC3 quantification of mosaic <italic>FRT +</italic> (control), <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> and <italic>drICE</italic><sup>RNAi</sup>;<italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> eye-antennal imaginal discs reveals significant increase of caspase activity both inside (autonomously) and outside (non-autonomously) of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones. Plotted is the mean signal intensity ±SD of autonomous and non-autonomous CC3 labelings, immediately adjacent to the clones. Analysis was performed by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p&lt;0.0001; **p&lt;0.01; ns – not significant. Ten discs per genotype were analyzed. (<bold>E</bold>) TUNEL assay as an apoptotic marker of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye discs. White arrows mark TUNEL-positive cells outside <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones, outlined by yellow dotted lines. (<bold>F</bold>) TUNEL quantification reveals that almost 90% of apoptotic cells in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs are outside of mutant clones. Autonomous and non-autonomous counts of TUNEL-positive cells were analyzed by paired student’s t-test. ****p&lt;0.0001. The distribution of TUNEL-positive cells in seven discs is plotted. <bold>Genotypes</bold>: (<bold>A</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/. <italic>FRT82B w</italic><sup>+</sup>; (<bold>B,E</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>C</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-drICE</italic><sup>RNAi</sup>; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26747.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Reduction of ROS results in loss of caspase activity in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs.</title><p>(<bold>A–F’</bold>) Cleaved caspase 3 (CC3) (red in (<bold>A–F</bold>); grey in (<bold>A’–F’</bold>) analysis of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>A</bold>) and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye imaginal discs with reduced <italic>dronc</italic> activity (<bold>B</bold>) and depleted ROS (<bold>C–F</bold>). Overall caspase activity is significantly reduced in panels (<bold>B–F</bold>). Scale bars: 50 μm. (<bold>G</bold>) CC3 quantification of the imaginal discs in (<bold>B’–F’</bold>) reveals significant reduction of caspase activity compared to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs (<bold>A’</bold>). + indicates <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> in otherwise wt background. Plotted is the mean signal intensity ±SD of CC3 labelings across the discs. Analysis was performed by one-way ANOVA with Holm-Sidak test for multiple comparisons. ****p&lt;0,0001; ***p&lt;0.001; ns – not significant. Ten discs per genotype were analyzed.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig3-figsupp1-v2"/></fig></fig-group><p>Labeling with the CC3 antibody indicates active Dronc both in apoptotic and non-apoptotic cells (<xref ref-type="bibr" rid="bib25">Fan and Bergmann, 2010</xref>; <xref ref-type="bibr" rid="bib27">Fan et al., 2014</xref>). Therefore, because of the strong tumor growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaics, we wondered if the CC3-positive cells in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones are actually apoptotic and labeled <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs with TUNEL, an apoptotic assay that detects DNA fragmentation, a hallmark of apoptosis downstream of effector caspases (<xref ref-type="bibr" rid="bib34">Gavrieli et al., 1992</xref>). Interestingly, although a few TUNEL-positive cells are detectable within <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones, the majority of TUNEL-positive cells are located outside the clones (<xref ref-type="fig" rid="fig3">Figure 3E,E’</xref>; arrows). Quantification reveals that almost 90% of all apoptotic cells in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs are outside the mutant clones (<xref ref-type="fig" rid="fig3">Figure 3F</xref>).</p><p>These observations allow us to make an important conclusion. Despite detectable caspase (Dronc) activity in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones by CC3 labeling, this activity does not appear to trigger a significant amount of apoptosis in these clones. In contrast, our genetic analysis suggest that the strong tumor growth phenotype of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye discs is dependent on caspases (<xref ref-type="fig" rid="fig2">Figure 2</xref>) suggesting that they have adopted a tumor-promoting function. This is surprising as caspase activity and apoptosis in general are thought to act as tumor suppressors (<xref ref-type="bibr" rid="bib38">Hanahan and Weinberg, 2011</xref>; <xref ref-type="bibr" rid="bib37">Hanahan and Weinberg, 2000</xref>). In fact, caspase activity in <italic>scrib</italic><sup>−/−</sup> single mutant cells does act as a tumor suppressor by killing them (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>). In contrast, in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells, this caspase activity persists, but does not appear to induce a significant amount of apoptosis. Therefore, these data suggest that <italic>Ras<sup>V12</sup></italic> maintains <italic>scrib</italic><sup>−/−</sup> cells in an ‘undead’-like condition, consistent with a previous report (<xref ref-type="bibr" rid="bib41">Hirabayashi et al., 2013</xref>). Furthermore, <italic>Ras<sup>V12</sup></italic> changes the activity of caspases to adopt a tumor-promoting role.</p></sec><sec id="s2-3"><title>Hemocyte recruitment to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumors depends on caspase-generated ROS</title><p>Next, we examined the role of ROS for neoplastic growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs. One known function of extracellular ROS is the recruitment and activation of <italic>Drosophila</italic> macrophages (hemocytes) in the ‘undead’ AiP model (<xref ref-type="bibr" rid="bib19">Diwanji and Bergmann, 2017a</xref>; <xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>; <xref ref-type="bibr" rid="bib20">Diwanji and Bergmann, 2017b</xref>). Hemocytes have been shown to be associated with <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib73">Pastor-Pareja et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Külshammer and Uhlirova, 2013</xref>). Therefore, we tested if ROS contribute to the recruitment and activation of hemocytes to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye imaginal discs. At control discs, hemocytes adhere in small cellular aggregates, mostly at the antennal disc (<xref ref-type="fig" rid="fig4">Figure 4A,A’,L</xref>). In contrast, they are recruited to neoplastic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumor sites in large numbers where they cover the eye portion of the disc (<xref ref-type="fig" rid="fig4">Figure 4B,B’</xref>; quantified in <xref ref-type="fig" rid="fig4">Figure 4K</xref>) consistent with previous reports (<xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib73">Pastor-Pareja et al., 2008</xref>; <xref ref-type="bibr" rid="bib53">Külshammer and Uhlirova, 2013</xref>). They also change their morphological appearance at neoplastic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs. They single out from the cellular clusters and develop cellular protrusions, similar to cytonemes (<xref ref-type="fig" rid="fig4">Figure 4M</xref>, arrows). This change in cellular behavior and morphology of hemocytes was also observed in the ‘undead’ AiP model (<xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.009</object-id><label>Figure 4.</label><caption><title>Caspase-generated ROS are required of recruitment and activation of hemocytes to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic eye/antennal imaginal discs.</title><p>Hemocytes were labeled with the NimC antibody (<xref ref-type="bibr" rid="bib52">Kurucz et al., 2007</xref>) (red in top panels; grey in (‘) panels and in (<bold>L–R</bold>)). Scale bars in (<bold>A–J’</bold>): 50 μm; in (<bold>L–R</bold>): 100 μm. (<bold>A,A’</bold>) Control mosaic discs (<italic>FRT</italic> +) carry small hemocyte clusters mostly at the antennal portion of the disc. (<bold>B,B’</bold>) <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs are covered by large quantities of hemocytes. + indicates <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> in otherwise wt background. (<bold>C–I</bold>) Hemocyte recruitment to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> eye/antennal imaginal discs is strongly impaired upon loss of ROS (<bold>C–F’</bold>) and caspase activity (<bold>G–I'</bold>). (<bold>J,J’</bold>) Expression of a dominant negative JNK transgene (<italic>JNK<sup>DN</sup></italic>) in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones blocks hemocyte recruitment. (<bold>K</bold>) Quantification of NimC labelings reveals that the number of hemocytes attached to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs is significantly lower when ROS levels or caspase activity are reduced in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones. To facilitate the quantification, the mean intensity of NimC labelings across the entire disc was determined, normalized to GFP (to account for the reduced size of ROS-depleted or caspase-inhibited <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones) and analyzed by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are referenced to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> and are indicated by asterisks above each column. ****p&lt;0.0001. Ten discs per genotype were analyzed. + indicates <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> in otherwise wt background. (<bold>L–R</bold>) High magnification images of hemocytes attached to the discs of indicated genotype. Note that in (<bold>M</bold>) hemocytes attached to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs extend cellular protrusions (arrows), similar to cytonemes. These protrusions are absent in hemocytes attached to control (<bold>L</bold>) and caspase-inhibited or ROS-depleted discs (<bold>N–R</bold>). + in (<bold>M</bold>) indicates <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> in otherwise wt background. <bold>Genotypes</bold>: (<bold>A,L</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/. <italic>FRT82B w</italic><sup>+</sup>; (<bold>B,M</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>C–I, N–R</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-Duox</italic><sup>RNAi</sup> (<bold>C</bold>), <italic>UAS-hCatS</italic> (<bold>D,N</bold>), <italic>UAS-SOD1</italic> (<bold>E</bold>), <italic>UAS-Catalase</italic> (<bold>F,O</bold>), <italic>UAS-SOD2</italic> (<bold>P</bold>), <italic>UAS-dronc</italic><sup>RNAi</sup> (<bold>G,Q</bold>), <italic>UAS-drICE</italic><sup>RNAi</sup> (<bold>H,R</bold>) and <italic>UAS-p35</italic> (<bold>I</bold>). (<bold>J</bold>) <italic>yw ey-FLP</italic>/<italic>UAS-JNK<sup>DN</sup>; act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>.</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig4-v2"/></fig><p>We examined if ROS and caspases are required for hemocyte recruitment to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs. Indeed, reduction of ROS strongly reduces the recruitment of hemocytes to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<xref ref-type="fig" rid="fig4">Figure 4C–F’</xref>). Likewise, the recruitment of hemocytes to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumors is impaired by loss of caspase activity (<xref ref-type="fig" rid="fig4">Figure 4G–I’</xref>). Quantification of hemocyte recruitment to ROS-depleted or caspase-inhibited <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs normalized to GFP (to account for the reduced size of ROS-depleted or caspase-inhibited <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones), revealed a significant loss of hemocytes compared to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<xref ref-type="fig" rid="fig4">Figure 4K</xref>). For example, more than 90% of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs expressing <italic>Duox</italic> RNAi are not attached by any hemocyte despite the presence of many small clones (<xref ref-type="fig" rid="fig4">Figure 4C’</xref>). Furthermore, in addition to the significant loss of hemocytes, the few hemocytes that are attached to ROS- and caspase-depleted <italic>scrib Ras<sup>V12</sup></italic> discs (<xref ref-type="fig" rid="fig4">Figure 4D’–I’</xref>), display the naive morphology seen at control discs (<xref ref-type="fig" rid="fig4">Figure 4N–R</xref>). These observations provide strong evidence that caspase-dependent generation of ROS is essential for recruitment and activation of hemocytes to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumors.</p></sec><sec id="s2-4"><title>Caspase activation and ROS generation depends on JNK signaling</title><p>As reported previously, JNK activity is strongly induced in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones (<xref ref-type="fig" rid="fig5">Figure 5C</xref>) and is essential for the neoplastic phenotype of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic animals (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib56">Leong et al., 2009</xref>; <xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>). In fact, activation of JNK in oncogenic <italic>Ras<sup>V12</sup></italic> background is sufficient to trigger a neoplastic tumor phenotype similar to the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> condition (<xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib89">Uhlirova and Bohmann, 2006</xref>). Therefore, we examined the relation between ROS, caspases and JNK signaling. In a first set of experiments, we blocked JNK signaling by expressing a dominant negative <italic>JNK</italic> construct (<italic>JNK<sup>DN</sup></italic>) in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones. In <italic>JNK<sup>DN</sup></italic>-expressing <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones, caspase activity (CC3) and ROS production are strongly reduced (<xref ref-type="fig" rid="fig5">Figure 5A–B’</xref>). Likewise, the recruitment and activation of hemocytes is strongly impaired at <italic>JNK<sup>DN</sup>; scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> discs (<xref ref-type="fig" rid="fig4">Figure 4J</xref>) consistent with a previous report (<xref ref-type="bibr" rid="bib53">Külshammer and Uhlirova, 2013</xref>). These findings suggest that caspase activation, ROS generation and hemocyte activation are dependent on JNK signaling.</p><fig-group><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.010</object-id><label>Figure 5.</label><caption><title>JNK acts upstream and downstream of caspase activation and ROS generation.</title><p>(<bold>A–B’</bold>) Expression of <italic>JNK<sup>DN</sup></italic> in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones inhibits caspase activity (A,A’; CC3) and ROS generation (B,B’; DHE). Scale bars: 50 μm. (<bold>C–K’</bold>) pJNK labeling (red in (<bold>C–K</bold>); grey in (<bold>C’–K’</bold>)) as JNK marker in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>C,C’</bold>), <italic>JNK<sup>DN</sup></italic>-expressing <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> (<bold>D,D’</bold>) and ROS-depleted or caspase-inhibited <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<bold>E–K’</bold>). The strong pJNK labeling in (<bold>C,C’</bold>) is significantly reduced in (<bold>D–K’</bold>). Scale bars: 50 μm. (<bold>L</bold>) The mean intensity of pJNK labelings in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones in panels (<bold>C’–K’</bold>) is significantly reduced upon ROS-depletion or reduction of caspase activity. Analysis of JNK labelings was done by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are referenced to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> and are indicated by asterisks above each column. ****p&lt;0.0001. At least ten discs per genotype were analyzed. <bold>Genotypes</bold>: (<bold>A,B,D</bold>) <italic>yw ey-FLP</italic>/<italic>UAS-JNK<sup>DN</sup>; act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>C</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>E–K</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-dronc</italic><sup>RNAi</sup> (<bold>E</bold>), <italic>UAS-drICE</italic><sup>RNAi</sup> (<bold>F</bold>), <italic>UAS-p35</italic> (<bold>G</bold>), <italic>UAS-Duox</italic><sup>RNAi</sup> (<bold>H</bold>), <italic>UAS-hCatS</italic> (<bold>I</bold>), <italic>UAS-Catalase</italic> (<bold>J</bold>) and <italic>UAS-SOD2</italic> (<bold>K</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig5-v2"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.26747.011</object-id><label>Figure 5—figure supplement 1.</label><caption><title>MMP1 labeling is reduced in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones with reduced ROS or caspase activity.</title><p>(<bold>A–H’</bold>) MMP1 labeling (red in (<bold>A–H</bold>); grey in (<bold>A’–H’</bold>)) as JNK marker in control discs (<italic>FRT +</italic>) (<bold>A,A’</bold>), <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<bold>B,B’</bold>) and ROS-depleted or caspase-inhibited <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mosaic discs (<bold>C–H’</bold>). The strong MMP1 labeling in (<bold>B,B’</bold>) is significantly reduced in (<bold>C–H’</bold>). Arrowheads in (<bold>C,C’</bold>) highlight representative examples of clones with low (white) or no (yellow) MMP1 labeling. Scale bars: 50 μm. (<bold>I</bold>) The mean intensity of MMP1 labelings in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones in panels (<bold>C’–H’</bold>) is significantly reduced upon ROS-depletion or reduction of caspase activity compared to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones (<bold>B’</bold>). Analysis of MMP1 labelings was done by one-way ANOVA with Holm-Sidak test for multiple comparisons. Error bars are SD. P values are referenced to <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> and are indicated by asterisks above each column. ****p&lt;0.0001, ns – not significant. At least ten discs per genotype were analyzed. <bold>Genotypes</bold>: (<bold>A</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>FRT82B w</italic><sup>+</sup>; (<bold>B</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/+; <italic>FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic>; (<bold>C–H</bold>) <italic>yw ey-FLP</italic>/+; <italic>act</italic>&gt;<italic>y</italic><sup>+</sup>&gt;<italic>Gal4</italic>, <italic>UAS-GFP<sup>56ST</sup></italic>/<italic>UAS-X; FRT82B tub-Gal80</italic>/<italic>UAS-Ras<sup>V12</sup> FRT82B scrib<sup>2</sup></italic> with <italic>UAS-X</italic> being <italic>UAS-Catalase</italic> (<bold>C</bold>), <italic>UAS-SOD1</italic> (<bold>D</bold>), <italic>UAS-SOD2</italic> (<bold>E</bold>), <italic>UAS-dronc</italic><sup>RNAi</sup> (<bold>F</bold>), <italic>UAS-drICE</italic><sup>RNAi</sup> (<bold>G</bold>) and <italic>UAS-p35</italic> (<bold>H</bold>).</p></caption><graphic mime-subtype="x-tiff" mimetype="image" xlink:href="elife-26747-fig5-figsupp1-v2"/></fig></fig-group><p>In the second set of experiments, we examined if there is a dependence of JNK signaling on caspases and ROS using anti-phosphoJNK (pJNK) antibody as a JNK activity marker. These labelings revealed a significant loss of JNK activity in caspase-inhibited or ROS-depleted <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones (<xref ref-type="fig" rid="fig5">Figure 5D–K’</xref>; quantified in <xref ref-type="fig" rid="fig5">Figure 5L</xref>). Similar results were obtained using MMP1 antibody labeling as an additional JNK marker (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). These observations suggest that the maintenance of JNK activity requires caspases and ROS. Combined, these results imply that JNK is acting both upstream (<xref ref-type="fig" rid="fig5">Figure 5A,B</xref>) and downstream (<xref ref-type="fig" rid="fig5">Figure 5E–L</xref>) of caspases and ROS. The easiest way to explain such a behavior is that caspases, ROS, hemocytes and JNK signaling constitute an amplification loop in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones similar to the ‘undead’ AiP model (<xref ref-type="bibr" rid="bib19">Diwanji and Bergmann, 2017a</xref>; <xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The traditional view of caspases holds that they counter tumorigenesis by eliminating tumor cells and thus mediate a tumor suppressor function (<xref ref-type="bibr" rid="bib37">Hanahan and Weinberg, 2000</xref>; <xref ref-type="bibr" rid="bib38">Hanahan and Weinberg, 2011</xref>). This tumor-suppressing function of caspases has been reported in mammalian systems (<xref ref-type="bibr" rid="bib3">Asselin-Labat et al., 2011</xref>; <xref ref-type="bibr" rid="bib42">Ho et al., 2009</xref>) and in <italic>Drosophila</italic>, where, for example, <italic>scrib</italic> mutant cells undergo caspase-dependent apoptosis in a JNK- and Eiger-dependent manner (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>). However, more recent work has suggested that caspases and apoptosis in general can also have the opposite, tumor-promoting function, both in flies and in mammals (<xref ref-type="bibr" rid="bib15">Cheng et al., 2015</xref>; <xref ref-type="bibr" rid="bib21">Donato et al., 2014</xref>; <xref ref-type="bibr" rid="bib43">Huang et al., 2011</xref>; <xref ref-type="bibr" rid="bib51">Kurtova et al., 2015</xref>; <xref ref-type="bibr" rid="bib58">Li et al., 2010</xref>; <xref ref-type="bibr" rid="bib96">Zhang et al., 2015</xref>); reviewed by (<xref ref-type="bibr" rid="bib80">Ryoo and Bergmann, 2012</xref>; <xref ref-type="bibr" rid="bib45">Ichim and Tait, 2016</xref>; <xref ref-type="bibr" rid="bib30">Fogarty and Bergmann, 2017</xref>). Furthermore, in <italic>Drosophila</italic> it was previously shown that oncogenic Ras switches the tumor-suppressing function of JNK and Eiger in <italic>scrib</italic><sup>−/−</sup> mutant cells to a tumor-promoting one in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells (<xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>; <xref ref-type="bibr" rid="bib23">Enomoto et al., 2015</xref>). Mechanistic details about this oncogenic switch have been largely elusive. Our data presented here imply that a critical step for this oncogenic switch is the conversion of caspase activity by oncogenic Ras.</p><p>Consistent with a previous report in different context (<xref ref-type="bibr" rid="bib41">Hirabayashi et al., 2013</xref>), our results demonstrated that oncogenic Ras can suppress the apoptotic activity of caspases and keeps <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells in an ‘undead’-like condition. While caspases may still induce apoptosis in a few tumor cells, they now largely promote generation of intra- and extracellular ROS which are required for malignant growth and tissue invasion of surviving neoplastic cells. Evidence that caspases are indeed activated in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> clones is not only provided in this study, but also in a report that showed that small malignant clones (<italic>lgl<sup>−/−</sup> Ras<sup>V12</sup></italic>) undergo caspase-mediated apoptosis and elimination in a similar way as <italic>scrib</italic> clones (<xref ref-type="bibr" rid="bib63">Menéndez et al., 2010</xref>). Only when mutant clones have reached a certain size, can they develop malignant tumors despite intrinsic caspase activation (<xref ref-type="bibr" rid="bib63">Menéndez et al., 2010</xref>; <xref ref-type="bibr" rid="bib5">Ballesteros-Arias et al., 2014</xref>).</p><p>Our data suggest that JNK activity acts both upstream and downstream of caspases and ROS generation in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones (<xref ref-type="fig" rid="fig5">Figure 5</xref>). It is possible that initially, when the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells form, a cell competition signal triggers JNK activation in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells, similar to the events in <italic>scrib</italic><sup>−/−</sup>-only mutant cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In both <italic>scrib</italic><sup>−/−</sup> and <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells, this JNK activity results in caspase activation (<xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig5">5A</xref>). However, due to the anti-apoptotic activity of <italic>Ras<sup>V12</sup></italic>, caspases induce only very little apoptosis in <italic>scrib Ras<sup>V12</sup></italic> clones (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Therefore, although caspases are active, most <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells do not die and thus are in an ‘undead’-like state. Caspases now promote the generation of extracellular ROS through activation of NADPH oxidase Duox. These ROS recruit and activate hemocytes (<xref ref-type="fig" rid="fig4">Figure 4</xref>). It is known that hemocytes can release Eiger (<xref ref-type="bibr" rid="bib17">Cordero et al., 2010</xref>; <xref ref-type="bibr" rid="bib72">Parisi et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>) which signals through its receptor Grindelwald (<xref ref-type="bibr" rid="bib1">Andersen et al., 2015</xref>) for further stimulation of JNK activity in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells. Thus, we postulate that JNK, caspases, ROS, hemocytes and Eiger constitute an amplification loop (<xref ref-type="fig" rid="fig6">Figure 6</xref>) which may be necessary for tumor initiation.</p><fig id="fig6" position="float"><object-id pub-id-type="doi">10.7554/eLife.26747.012</object-id><label>Figure 6.</label><caption><title>Mechanistic view about the conversion of caspases from tumor suppressors to tumors promoters in <italic>scrib Ras<sup>V12</sup></italic> mutant cells.</title><p>(<bold>A</bold>) After <italic>scrib</italic><sup>−/−</sup> mutant cells have formed in mosaic discs, a cell competition signal mediated by Eiger triggers JNK and caspase activity which induces apoptosis of <italic>scrib</italic> mutant cells (dashed outline of the cell). (<bold>B</bold>) After <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells have formed, JNK activity may be induced by the same cell competition signal as in <italic>scrib</italic><sup>−/−</sup> mutant cells (early). However, despite activation of JNK and caspases in <italic>scrib Ras<sup>V12</sup></italic> cells, Ras<sup>V12</sup> keeps these cells in an ‘undead’-like condition and enables caspases to initiate a feedback amplification loop involving ROS generation and recruitment of hemocytes which amplifies JNK and caspase activity (late). This amplification loop is necessary for malignant growth and invasion. Neighboring wild-type cells undergo apoptosis (dashed outline of the cell). The mechanism of non-autonomous apoptosis is not clear.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-26747-fig6-v2"/></fig><p>Evidence of an amplification loop is provided by the mutual dependence of caspases, ROS and JNK (<xref ref-type="fig" rid="fig5">Figure 5</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Similar amplification loops have been described in apoptotic and ‘undead’ cells (<xref ref-type="bibr" rid="bib92">Wells et al., 2006</xref>; <xref ref-type="bibr" rid="bib85">Shlevkov and Morata, 2012</xref>; <xref ref-type="bibr" rid="bib29">Fogarty et al., 2016</xref>). This amplification loop ensures persistent oncogenic signaling in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells. This is in striking contrast to <italic>scrib</italic><sup>−/−</sup> mutant cells alone in which JNK signaling triggers linear caspase activation and apoptosis (<xref ref-type="bibr" rid="bib10">Brumby and Richardson, 2003</xref>; <xref ref-type="bibr" rid="bib46">Igaki et al., 2006</xref>; <xref ref-type="bibr" rid="bib47">Igaki et al., 2009</xref>; <xref ref-type="bibr" rid="bib88">Uhlirova et al., 2005</xref>). In later stages of tumorigenesis, the amplification loop may have reached full strength and promotes malignant growth and invasion of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Amplification loops have also been observed in other neoplastic tumor models in <italic>Drosophila</italic>. For example, intestinal stem cell tumors form in response to an amplification loop (<xref ref-type="bibr" rid="bib14">Chen et al., 2016</xref>). In a glycolytic tumor model, ROS are also part of a amplification loop that facilitates metabolic reprogramming (<xref ref-type="bibr" rid="bib91">Wang et al., 2016</xref>). Thus, it is possible that tumorigenesis in general depends on amplification loops to sustain oncogenic signaling.</p><p>There are similarities and differences in the amplification loops of the ‘undead’ hyperplastic AiP model and the neoplastic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumor model. In both models, caspases, ROS, hemocytes and JNK are required for growth. However, regarding caspases, the ‘undead’ AiP model only involves the initiator caspase Dronc for growth (in fact, effector caspases are inhibited by P35 in this model) (<xref ref-type="bibr" rid="bib27">Fan et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Huh et al., 2004</xref>; <xref ref-type="bibr" rid="bib75">Pérez-Garijo et al., 2004</xref>; <xref ref-type="bibr" rid="bib77">Pérez-Garijo et al., 2009</xref>; <xref ref-type="bibr" rid="bib79">Ryoo et al., 2004</xref>). In contrast, the neoplastic <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> model requires both initiator (Dronc) and effector (DrICE) caspases. Inhibition of either suppresses malignant growth and invasion. Another interesting difference is the differential involvement of ROS. While only extracellular ROS are essential in the ‘undead’ AiP model, neoplastic growth of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells requires both intra- and extracellular ROS. Mitochondria are the likely source of intracellular ROS because expression of mitochondrial SOD2 can suppress tumor growth and invasion of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumors (<xref ref-type="fig" rid="fig1">Figure 1N</xref>). It is unclear if these two populations of ROS are dependent or independent of each other. Recently, it was shown in endothelial cells that Nox-derived ROS can trigger an increase in mitochondrially-derived ROS and loss of mitochondrial membrane potential suggesting a dependence of mitochondrial ROS from Nox-generated ROS (<xref ref-type="bibr" rid="bib83">Shafique et al., 2017</xref>). However, alternatively, it is also possible that intra- and extracellular ROS are produced independently by caspase activity, and both are separately required for neoplastic transformation.</p><p>Furthermore, while we mostly focused from the point-of-view of ‘undead’ AiP, it is also possible that ‘genuine’ AiP contributes to the tumor growth in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic>. Consistent with this notion is the observation that there are a few apoptotic cells in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant clones (<xref ref-type="fig" rid="fig3">Figure 3E’,F</xref>). Genuinely apoptotic cells can also produce ROS in <italic>Drosophila</italic> imaginal discs (<xref ref-type="bibr" rid="bib82">Santabárbara-Ruiz et al., 2015</xref>). Therefore, it is tempting to speculate that some of the differences between the ‘undead’ AiP model and the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> model are due to a combination of ‘undead’ and ‘genuine’ AiP in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic>. This may explain the differences in caspase requirement, the differences in ROS production and the different outcomes of growth – hyperplastic vs. neoplastic – between the ‘undead’ AiP and the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tumor models. Future work will address this important question.</p><p>Another important question for future studies will be to address how <italic>Ras<sup>V12</sup></italic> switches the activity of caspases from tumor-suppressors to tumor-promoters. A known target of survival signaling by <italic>Ras<sup>V12</sup></italic> is the pro-apoptotic gene Hid which acts upstream of caspase activation (<xref ref-type="bibr" rid="bib6">Bergmann et al., 1998</xref>; <xref ref-type="bibr" rid="bib50">Kurada and White, 1998</xref>). Because Eiger and JNK can induce expression of <italic>hid</italic> (<xref ref-type="bibr" rid="bib65">Moreno et al., 2002</xref>), it is possible that Hid activity is inhibited by oncogenic Ras. However, while we do not exclude this possibility, it alone may not be sufficient to explain the altered caspase activity because inhibition of <italic>hid</italic> would result in loss of caspase activity. However, caspases are still active in <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> mutant cells (<xref ref-type="fig" rid="fig3">Figure 3B,D</xref>) and they are also able to induce apoptosis at least in a small amount of mutant cells (<xref ref-type="fig" rid="fig3">Figure 3E,F</xref>). Therefore, it is possible that <italic>Ras<sup>V12</sup></italic> modifies caspase activity in a different manner – directly or indirectly – for non-apoptotic ROS generation.</p><p>Oncogenic Ras is mediating many steps in the tumorigenic process of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> tissue. It changes the transcriptome of these cells and modifies the downstream activities of JNK (<xref ref-type="bibr" rid="bib4">Atkins et al., 2016</xref>; <xref ref-type="bibr" rid="bib54">Külshammer et al., 2015</xref>). However, as shown in this work, a critical step mediated by <italic>Ras<sup>V12</sup></italic> is the modification of caspase activity – directly or indirectly – in the early stage of tumorigenesis in a way that the cells survive. At present it is unclear if the caspase-modulating activity of <italic>Ras<sup>V12</sup></italic> is dependent on transcription. There may not be enough time for a transcriptional response by the cell to escape the apoptotic activity of caspases. Consistently, work by others has suggested that changes in the transcriptome alone does not fully explain the neoplastic phenotype of <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> cells and that other potentially non-transcriptional processes are involved (<xref ref-type="bibr" rid="bib4">Atkins et al., 2016</xref>). Modification of caspase activity may be one of these non-transcriptional processes.</p><p>Non-apoptotic functions of caspases have been reported (<xref ref-type="bibr" rid="bib84">Shalini et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Fogarty and Bergmann, 2017</xref>; <xref ref-type="bibr" rid="bib66">Mukherjee and Williams, 2017</xref>; <xref ref-type="bibr" rid="bib67">Nakajima and Kuranaga, 2017</xref>). However, it is largely unknown how cells survive in the presence of activated caspases during non-apoptotic processes. It is possible that a reduction of caspase activity below a certain apoptotic threshold is sufficient for survival. Other models include changes in the subcellular localization of caspases or interaction with modifying factors such as Tango7 (<xref ref-type="bibr" rid="bib18">D'Brot et al., 2013</xref>). Interesting in this respect is a recent study which showed that mitochondrially-derived SCSβ restricts caspase activity for spermatid maturation in the <italic>Drosophila</italic> testis (<xref ref-type="bibr" rid="bib2">Aram et al., 2016</xref>). Since mitochondria release apoptotic signaling molecules such as cytochrome c and Smac during apoptosis (<xref ref-type="bibr" rid="bib31">Fuchs and Steller, 2011</xref>), it may also be possible that they release signals such as SCSβ or related factors which modulate the activity of caspases for non-apoptotic functions. More work is necessary to address these essential questions for understanding of tumor initiation and progression.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title><italic>Drosophila</italic> genetics</title><p>The <italic>scrib</italic> allele used is <italic>scrib<sup>2</sup></italic> (also known as <italic>scrib<sup>673</sup></italic>) (<xref ref-type="bibr" rid="bib9">Bilder and Perrimon, 2000</xref>). The recombinant <italic>UAS-Ras<sup>V12</sup> FRT82B scrib</italic><sup>2</sup> (<xref ref-type="bibr" rid="bib13">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="bib74">Pérez et al., 2015</xref>) line was a kind gift of Madhuri Kango-Singh (U Dayton, OH, USA). The MARCM system (<xref ref-type="bibr" rid="bib55">Lee and Luo, 1999</xref>) with <italic>ey-FLP</italic> (<xref ref-type="bibr" rid="bib68">Newsome et al., 2000</xref>) was used to generate mosaics of eye/antennal imaginal discs and experimental clones were marked by GFP. In (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), we used a modified MARCM system that marks clones with myrRFP (<xref ref-type="bibr" rid="bib12">Chabu and Xu, 2014</xref>). The wt control line (<italic>FRT</italic> +) is <italic>FRT82B</italic> (<xref ref-type="bibr" rid="bib94">Xu and Rubin, 1993</xref>).</p><p>The following transgenes are all inserted on chromosome 2 and were crossed into the <italic>scrib</italic><sup>−/−</sup> <italic>Ras<sup>V12</sup></italic> background for analysis: <italic>UAS-lacZ</italic> (Bloomington, BL3955), <italic>UAS-Duox</italic> RNAi and <italic>UAS-hCatS</italic> (a kind gift of Won-Jae Lee) (<xref ref-type="bibr" rid="bib35">Ha et al., 2005a</xref>; <xref ref-type="bibr" rid="bib36">Ha et al., 2005b2005</xref>), <italic>UAS-Catalase</italic> (BL24621), <italic>UAS-SOD1</italic> (BL24754), <italic>UAS-SOD2</italic> (BL24494), UAS-p35 (BL5072), <italic>UAS-dronc</italic> RNAi and <italic>UAS-drICE RNAi</italic> (a kind gift of Pascal Meier) (<xref ref-type="bibr" rid="bib57">Leulier et al., 2006</xref>). <italic>UAS-JNK<sup>DN</sup></italic> (aka <italic>UAS-bsk<sup>DN</sup></italic>) (BL6409) is an insertion on X chromosome. Crosses were incubated at either 22° or 25°C.</p></sec><sec id="s4-2"><title>Imaging and quantification</title><p>DHE and H<sub>2</sub>DCF-DA (both from Invitrogen/Molecular Probes) labeling of unfixed tissue was performed as described (<xref ref-type="bibr" rid="bib70">Owusu-Ansah et al., 2008</xref>). TUNEL labeling (Roche) was done according to the manufacturer’s instructions. Antibody labelings were done on fixed tissue following standard procedures (<xref ref-type="bibr" rid="bib26">Fan and Bergmann, 2014</xref>; <xref ref-type="bibr" rid="bib28">Fogarty and Bergmann, 2014</xref>). The following antibodies were used: cleaved caspase-3 (CC3; Cell Signaling Technology); NimC (kind gift of I. Andó) (<xref ref-type="bibr" rid="bib52">Kurucz et al., 2007</xref>); MMP1 (Developmental Studies Hybridoma Bank (DSHB)) and pJNK (Promega). Secondary antibodies were donkey Fab fragments from Jackson Immunoresearch. Eye/antennal cephalic complexes were counterlabeled with the nuclear dye DAPI to visualize tissue outline. Images were taken with a Zeiss LSM700 confocal microscope. For quantification of confocal images, the ‘Record Measurement’ function of Photoshop was used. Clones were outlined and signal intensity determined. Multiple clones of five to ten imaginal discs per genotype obtained in three independent experiments were measured. Analysis and graph generation was done using GraphPad Prism 7.03. The statistical method and the P values are indicated in the figure legends.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank István Andó, Madhuri Kango-Singh, Won Jae Lee, Pascal Meier, Tian Xu, the Bloomington and Vienna stock centers for fly stocks and reagents; Eric Baehrecke, Yun Fan and Caitlin E. Fogarty for stimulating discussions. This work was supported by MIRA award R35 GM118330 from the NIH/NIGMS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing—original draft</p></fn><fn fn-type="con" id="con3"><p>Data curation, Formal analysis, Investigation</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.26747.013</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-26747-transrepform-v2.docx"/></supplementary-material></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname> <given-names>DS</given-names></name><name><surname>Colombani</surname> <given-names>J</given-names></name><name><surname>Palmerini</surname> <given-names>V</given-names></name><name><surname>Chakrabandhu</surname> <given-names>K</given-names></name><name><surname>Boone</surname> <given-names>E</given-names></name><name><surname>Röthlisberger</surname> <given-names>M</given-names></name><name><surname>Toggweiler</surname> <given-names>J</given-names></name><name><surname>Basler</surname> <given-names>K</given-names></name><name><surname>Mapelli</surname> <given-names>M</given-names></name><name><surname>Hueber</surname> <given-names>AO</given-names></name><name><surname>Léopold</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth</article-title><source>Nature</source><volume>522</volume><fpage>482</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.1038/nature14298</pub-id><pub-id pub-id-type="pmid">25874673</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aram</surname> <given-names>L</given-names></name><name><surname>Braun</surname> <given-names>T</given-names></name><name><surname>Braverman</surname> <given-names>C</given-names></name><name><surname>Kaplan</surname> <given-names>Y</given-names></name><name><surname>Ravid</surname> <given-names>L</given-names></name><name><surname>Levin-Zaidman</surname> <given-names>S</given-names></name><name><surname>Arama</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A krebs cycle component limits caspase activation rate through mitochondrial surface restriction of CRL activation</article-title><source>Developmental Cell</source><volume>37</volume><fpage>15</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.02.025</pub-id><pub-id pub-id-type="pmid">27052834</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asselin-Labat</surname> <given-names>ML</given-names></name><name><surname>Sutherland</surname> <given-names>KD</given-names></name><name><surname>Vaillant</surname> <given-names>F</given-names></name><name><surname>Gyorki</surname> <given-names>DE</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Holroyd</surname> <given-names>S</given-names></name><name><surname>Breslin</surname> <given-names>K</given-names></name><name><surname>Ward</surname> <given-names>T</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Bath</surname> <given-names>ML</given-names></name><name><surname>Deb</surname> <given-names>S</given-names></name><name><surname>Fox</surname> <given-names>SB</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Lindeman</surname> <given-names>GJ</given-names></name><name><surname>Visvader</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14</article-title><source>Molecular and Cellular Biology</source><volume>31</volume><fpage>4609</fpage><lpage>4622</lpage><pub-id pub-id-type="doi">10.1128/MCB.05766-11</pub-id><pub-id pub-id-type="pmid">21930782</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atkins</surname> <given-names>M</given-names></name><name><surname>Potier</surname> <given-names>D</given-names></name><name><surname>Romanelli</surname> <given-names>L</given-names></name><name><surname>Jacobs</surname> <given-names>J</given-names></name><name><surname>Mach</surname> <given-names>J</given-names></name><name><surname>Hamaratoglu</surname> <given-names>F</given-names></name><name><surname>Aerts</surname> <given-names>S</given-names></name><name><surname>Halder</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An ectopic network of transcription factors regulated by hippo signaling drives growth and invasion of a malignant tumor model</article-title><source>Current Biology</source><volume>26</volume><fpage>2101</fpage><lpage>2113</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2016.06.035</pub-id><pub-id pub-id-type="pmid">27476594</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballesteros-Arias</surname> <given-names>L</given-names></name><name><surname>Saavedra</surname> <given-names>V</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cell competition may function either as tumour-suppressing or as tumour-stimulating factor in Drosophila</article-title><source>Oncogene</source><volume>33</volume><fpage>4377</fpage><lpage>4384</lpage><pub-id pub-id-type="doi">10.1038/onc.2013.407</pub-id><pub-id pub-id-type="pmid">24096487</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergmann</surname> <given-names>A</given-names></name><name><surname>Agapite</surname> <given-names>J</given-names></name><name><surname>McCall</surname> <given-names>K</given-names></name><name><surname>Steller</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling</article-title><source>Cell</source><volume>95</volume><fpage>331</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81765-1</pub-id><pub-id pub-id-type="pmid">9814704</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergstralh</surname> <given-names>DT</given-names></name><name><surname>St Johnston</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Epithelial cell polarity: what flies can teach us about cancer</article-title><source>Essays In Biochemistry</source><volume>53</volume><fpage>129</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1042/bse0530129</pub-id><pub-id pub-id-type="pmid">22928513</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilder</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Perrimon</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cooperative regulation of cell polarity and growth by Drosophila tumor suppressors</article-title><source>Science</source><volume>289</volume><fpage>113</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1126/science.289.5476.113</pub-id><pub-id pub-id-type="pmid">10884224</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilder</surname> <given-names>D</given-names></name><name><surname>Perrimon</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Localization of apical epithelial determinants by the basolateral PDZ protein Scribble</article-title><source>Nature</source><volume>403</volume><fpage>676</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1038/35001108</pub-id><pub-id pub-id-type="pmid">10688207</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brumby</surname> <given-names>AM</given-names></name><name><surname>Richardson</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila</article-title><source>The EMBO Journal</source><volume>22</volume><fpage>5769</fpage><lpage>5779</lpage><pub-id pub-id-type="doi">10.1093/emboj/cdg548</pub-id><pub-id pub-id-type="pmid">14592975</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brumby</surname> <given-names>AM</given-names></name><name><surname>Goulding</surname> <given-names>KR</given-names></name><name><surname>Schlosser</surname> <given-names>T</given-names></name><name><surname>Loi</surname> <given-names>S</given-names></name><name><surname>Galea</surname> <given-names>R</given-names></name><name><surname>Khoo</surname> <given-names>P</given-names></name><name><surname>Bolden</surname> <given-names>JE</given-names></name><name><surname>Aigaki</surname> <given-names>T</given-names></name><name><surname>Humbert</surname> <given-names>PO</given-names></name><name><surname>Richardson</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Identification of novel Ras-cooperating oncogenes in Drosophila melanogaster: a RhoGEF/Rho-family/JNK pathway is a central driver of tumorigenesis</article-title><source>Genetics</source><volume>188</volume><fpage>105</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.127910</pub-id><pub-id pub-id-type="pmid">21368274</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabu</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Oncogenic Ras stimulates Eiger/TNF exocytosis to promote growth</article-title><source>Development</source><volume>141</volume><fpage>4729</fpage><lpage>4739</lpage><pub-id pub-id-type="doi">10.1242/dev.108092</pub-id><pub-id pub-id-type="pmid">25411211</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>CL</given-names></name><name><surname>Schroeder</surname> <given-names>MC</given-names></name><name><surname>Kango-Singh</surname> <given-names>M</given-names></name><name><surname>Tao</surname> <given-names>C</given-names></name><name><surname>Halder</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tumor suppression by cell competition through regulation of the Hippo pathway</article-title><source>Proceedings of the National Academy of Sciences</source><volume>109</volume><fpage>484</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1073/pnas.1113882109</pub-id><pub-id pub-id-type="pmid">22190496</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Xu</surname> <given-names>N</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Cai</surname> <given-names>T</given-names></name><name><surname>Xi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A feedback amplification loop between stem cells and their progeny promotes tissue regeneration and tumorigenesis</article-title><source>eLife</source><volume>5</volume><elocation-id>e14330</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.14330</pub-id><pub-id pub-id-type="pmid">27187149</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name><name><surname>Ma</surname> <given-names>J</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Xu</surname> <given-names>B</given-names></name><name><surname>Xiong</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dying tumor cells stimulate proliferation of living tumor cells via caspase-dependent protein kinase Cδ activation in pancreatic ductal adenocarcinoma</article-title><source>Molecular Oncology</source><volume>9</volume><fpage>105</fpage><lpage>114</lpage><pub-id pub-id-type="doi">10.1016/j.molonc.2014.07.024</pub-id><pub-id pub-id-type="pmid">25156550</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chera</surname> <given-names>S</given-names></name><name><surname>Ghila</surname> <given-names>L</given-names></name><name><surname>Dobretz</surname> <given-names>K</given-names></name><name><surname>Wenger</surname> <given-names>Y</given-names></name><name><surname>Bauer</surname> <given-names>C</given-names></name><name><surname>Buzgariu</surname> <given-names>W</given-names></name><name><surname>Martinou</surname> <given-names>JC</given-names></name><name><surname>Galliot</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Apoptotic cells provide an unexpected source of Wnt3 signaling to drive hydra head regeneration</article-title><source>Developmental Cell</source><volume>17</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.07.014</pub-id><pub-id pub-id-type="pmid">19686688</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cordero</surname> <given-names>JB</given-names></name><name><surname>Macagno</surname> <given-names>JP</given-names></name><name><surname>Stefanatos</surname> <given-names>RK</given-names></name><name><surname>Strathdee</surname> <given-names>KE</given-names></name><name><surname>Cagan</surname> <given-names>RL</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter</article-title><source>Developmental Cell</source><volume>18</volume><fpage>999</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.05.014</pub-id><pub-id pub-id-type="pmid">20627081</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Brot</surname> <given-names>A</given-names></name><name><surname>Chen</surname> <given-names>P</given-names></name><name><surname>Vaishnav</surname> <given-names>M</given-names></name><name><surname>Yuan</surname> <given-names>S</given-names></name><name><surname>Akey</surname> <given-names>CW</given-names></name><name><surname>Abrams</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Tango7 directs cellular remodeling by the Drosophila apoptosome</article-title><source>Genes &amp; Development</source><volume>27</volume><fpage>1650</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1101/gad.219287.113</pub-id><pub-id pub-id-type="pmid">23913920</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diwanji</surname> <given-names>N</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017a</year><article-title>The beneficial role of extracellular reactive oxygen species in apoptosis-induced compensatory proliferation</article-title><source>Fly</source><volume>11</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1080/19336934.2016.1222997</pub-id><pub-id pub-id-type="pmid">27575697</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diwanji</surname> <given-names>N</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017b</year><article-title>An unexpected friend - ROS in apoptosis-induced compensatory proliferation: Implications for regeneration and cancer</article-title><source>Seminars in Cell &amp; Developmental Biology</source><pub-id pub-id-type="doi">10.1016/j.semcdb.2017.07.004</pub-id><pub-id pub-id-type="pmid">28688927</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname> <given-names>AL</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Zimmerman</surname> <given-names>MA</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Caspase 3 promotes surviving melanoma tumor cell growth after cytotoxic therapy</article-title><source>Journal of Investigative Dermatology</source><volume>134</volume><fpage>1686</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1038/jid.2014.18</pub-id><pub-id pub-id-type="pmid">24434746</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsum</surname> <given-names>I</given-names></name><name><surname>Yates</surname> <given-names>L</given-names></name><name><surname>Humbert</surname> <given-names>PO</given-names></name><name><surname>Richardson</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The Scribble-Dlg-Lgl polarity module in development and cancer: from flies to man</article-title><source>Essays In Biochemistry</source><volume>53</volume><fpage>141</fpage><lpage>168</lpage><pub-id pub-id-type="doi">10.1042/bse0530141</pub-id><pub-id pub-id-type="pmid">22928514</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enomoto</surname> <given-names>M</given-names></name><name><surname>Kizawa</surname> <given-names>D</given-names></name><name><surname>Ohsawa</surname> <given-names>S</given-names></name><name><surname>Igaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity</article-title><source>Developmental Biology</source><volume>403</volume><fpage>162</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2015.05.001</pub-id><pub-id pub-id-type="pmid">25967126</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye</article-title><source>Developmental Cell</source><volume>14</volume><fpage>399</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2008.01.003</pub-id><pub-id pub-id-type="pmid">18331718</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The cleaved-Caspase-3 antibody is a marker of Caspase-9-like DRONC activity in Drosophila</article-title><source>Cell Death and Differentiation</source><volume>17</volume><fpage>534</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1038/cdd.2009.185</pub-id><pub-id pub-id-type="pmid">19960024</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Multiple mechanisms modulate distinct cellular susceptibilities toward apoptosis in the developing Drosophila eye</article-title><source>Developmental Cell</source><volume>30</volume><fpage>48</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2014.05.007</pub-id><pub-id pub-id-type="pmid">24981611</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Hernandez</surname> <given-names>J</given-names></name><name><surname>Yenigun</surname> <given-names>VB</given-names></name><name><surname>Hertlein</surname> <given-names>G</given-names></name><name><surname>Fogarty</surname> <given-names>CE</given-names></name><name><surname>Lindblad</surname> <given-names>JL</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genetic models of apoptosis-induced proliferation decipher activation of JNK and identify a requirement of EGFR signaling for tissue regenerative responses in Drosophila</article-title><source>PLoS Genetics</source><volume>10</volume><elocation-id>e1004131</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1004131</pub-id><pub-id pub-id-type="pmid">24497843</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>CE</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Detecting caspase activity in Drosophila larval imaginal discs</article-title><source>Methods in Molecular Biology</source><volume>1133</volume><fpage>109</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-0357-3_7</pub-id><pub-id pub-id-type="pmid">24567098</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>CE</given-names></name><name><surname>Diwanji</surname> <given-names>N</given-names></name><name><surname>Lindblad</surname> <given-names>JL</given-names></name><name><surname>Tare</surname> <given-names>M</given-names></name><name><surname>Amcheslavsky</surname> <given-names>A</given-names></name><name><surname>Makhijani</surname> <given-names>K</given-names></name><name><surname>Brückner</surname> <given-names>K</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Extracellular reactive oxygen species drive apoptosis-induced proliferation via drosophila macrophages</article-title><source>Current Biology</source><volume>26</volume><fpage>575</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2015.12.064</pub-id><pub-id pub-id-type="pmid">26898463</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fogarty</surname> <given-names>CE</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Killers creating new life: caspases drive apoptosis-induced proliferation in tissue repair and disease</article-title><source>Cell Death and Differentiation</source><volume>24</volume><fpage>1390</fpage><lpage>1400</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.47</pub-id><pub-id pub-id-type="pmid">28362431</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname> <given-names>Y</given-names></name><name><surname>Steller</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Programmed cell death in animal development and disease</article-title><source>Cell</source><volume>147</volume><fpage>742</fpage><lpage>758</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.10.033</pub-id><pub-id pub-id-type="pmid">22078876</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gateff</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Malignant neoplasms of genetic origin in Drosophila melanogaster</article-title><source>Science</source><volume>200</volume><fpage>1448</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.1126/science.96525</pub-id><pub-id pub-id-type="pmid">96525</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gateff</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Tumor suppressor and overgrowth suppressor genes of Drosophila melanogaster: developmental aspects</article-title><source>The International journal of developmental biology</source><volume>38</volume><fpage>565</fpage><lpage>590</lpage><pub-id pub-id-type="pmid">7779680</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gavrieli</surname> <given-names>Y</given-names></name><name><surname>Sherman</surname> <given-names>Y</given-names></name><name><surname>Ben-Sasson</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation</article-title><source>The Journal of Cell Biology</source><volume>119</volume><fpage>493</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1083/jcb.119.3.493</pub-id><pub-id pub-id-type="pmid">1400587</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname> <given-names>EM</given-names></name><name><surname>Oh</surname> <given-names>CT</given-names></name><name><surname>Bae</surname> <given-names>YS</given-names></name><name><surname>Lee</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2005">2005a</year><article-title>A direct role for dual oxidase in Drosophila gut immunity</article-title><source>Science</source><volume>310</volume><fpage>847</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1126/science.1117311</pub-id><pub-id pub-id-type="pmid">16272120</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ha</surname> <given-names>EM</given-names></name><name><surname>Oh</surname> <given-names>CT</given-names></name><name><surname>Ryu</surname> <given-names>JH</given-names></name><name><surname>Bae</surname> <given-names>YS</given-names></name><name><surname>Kang</surname> <given-names>SW</given-names></name><name><surname>Jang</surname> <given-names>IH</given-names></name><name><surname>Brey</surname> <given-names>PT</given-names></name><name><surname>Lee</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>An antioxidant system required for host protection against gut infection in Drosophila</article-title><source>Developmental Cell</source><volume>8</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.11.007</pub-id><pub-id pub-id-type="pmid">15621536</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname> <given-names>D</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The hallmarks of cancer</article-title><source>Cell</source><volume>100</volume><fpage>57</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81683-9</pub-id><pub-id pub-id-type="pmid">10647931</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname> <given-names>D</given-names></name><name><surname>Weinberg</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname> <given-names>CJ</given-names></name><name><surname>Yoo</surname> <given-names>SJ</given-names></name><name><surname>Peterson</surname> <given-names>EP</given-names></name><name><surname>Wang</surname> <given-names>SL</given-names></name><name><surname>Vernooy</surname> <given-names>SY</given-names></name><name><surname>Hay</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The Drosophila caspase DRONC cleaves following glutamate or aspartate and is regulated by DIAP1, HID, and GRIM</article-title><source>The Journal of Biological Chemistry</source><volume>275</volume><fpage>27084</fpage><lpage>27093</lpage><pub-id pub-id-type="doi">10.1074/jbc.M000869200</pub-id><pub-id pub-id-type="pmid">10825159</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hay</surname> <given-names>BA</given-names></name><name><surname>Wolff</surname> <given-names>T</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Expression of baculovirus P35 prevents cell death in Drosophila</article-title><source>Development</source><volume>120</volume><fpage>2121</fpage><lpage>2129</lpage><pub-id pub-id-type="pmid">7925015</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirabayashi</surname> <given-names>S</given-names></name><name><surname>Baranski</surname> <given-names>TJ</given-names></name><name><surname>Cagan</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Transformed Drosophila cells evade diet-mediated insulin resistance through wingless signaling</article-title><source>Cell</source><volume>154</volume><fpage>664</fpage><lpage>675</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2013.06.030</pub-id><pub-id pub-id-type="pmid">23911328</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname> <given-names>LH</given-names></name><name><surname>Taylor</surname> <given-names>R</given-names></name><name><surname>Dorstyn</surname> <given-names>L</given-names></name><name><surname>Cakouros</surname> <given-names>D</given-names></name><name><surname>Bouillet</surname> <given-names>P</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A tumor suppressor function for caspase-2</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><volume>106</volume><fpage>5336</fpage><lpage>5341</lpage><pub-id pub-id-type="doi">10.1073/pnas.0811928106</pub-id><pub-id pub-id-type="pmid">19279217</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name><name><surname>Liu</surname> <given-names>FF</given-names></name><name><surname>O'Sullivan</surname> <given-names>B</given-names></name><name><surname>He</surname> <given-names>Z</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Tan</surname> <given-names>AC</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Shen</surname> <given-names>J</given-names></name><name><surname>Han</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>XJ</given-names></name><name><surname>Thorburn</surname> <given-names>J</given-names></name><name><surname>Thorburn</surname> <given-names>A</given-names></name><name><surname>Jimeno</surname> <given-names>A</given-names></name><name><surname>Raben</surname> <given-names>D</given-names></name><name><surname>Bedford</surname> <given-names>JS</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy</article-title><source>Nature Medicine</source><volume>17</volume><fpage>860</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1038/nm.2385</pub-id><pub-id pub-id-type="pmid">21725296</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname> <given-names>JR</given-names></name><name><surname>Guo</surname> <given-names>M</given-names></name><name><surname>Hay</surname> <given-names>BA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Compensatory proliferation induced by cell death in the Drosophila wing disc requires activity of the apical cell death caspase Dronc in a nonapoptotic role</article-title><source>Current Biology</source><volume>14</volume><fpage>1262</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.06.015</pub-id><pub-id pub-id-type="pmid">15268856</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ichim</surname> <given-names>G</given-names></name><name><surname>Tait</surname> <given-names>SW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A fate worse than death: apoptosis as an oncogenic process</article-title><source>Nature Reviews Cancer</source><volume>16</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1038/nrc.2016.58</pub-id><pub-id pub-id-type="pmid">27364482</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igaki</surname> <given-names>T</given-names></name><name><surname>Pagliarini</surname> <given-names>RA</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila</article-title><source>Current Biology</source><volume>16</volume><fpage>1139</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.04.042</pub-id><pub-id pub-id-type="pmid">16753569</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igaki</surname> <given-names>T</given-names></name><name><surname>Pastor-Pareja</surname> <given-names>JC</given-names></name><name><surname>Aonuma</surname> <given-names>H</given-names></name><name><surname>Miura</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Intrinsic tumor suppression and epithelial maintenance by endocytic activation of Eiger/TNF signaling in Drosophila</article-title><source>Developmental Cell</source><volume>16</volume><fpage>458</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.01.002</pub-id><pub-id pub-id-type="pmid">19289090</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katheder</surname> <given-names>NS</given-names></name><name><surname>Khezri</surname> <given-names>R</given-names></name><name><surname>O'Farrell</surname> <given-names>F</given-names></name><name><surname>Schultz</surname> <given-names>SW</given-names></name><name><surname>Jain</surname> <given-names>A</given-names></name><name><surname>Rahman</surname> <given-names>MM</given-names></name><name><surname>Schink</surname> <given-names>KO</given-names></name><name><surname>Theodossiou</surname> <given-names>TA</given-names></name><name><surname>Johansen</surname> <given-names>T</given-names></name><name><surname>Juhász</surname> <given-names>G</given-names></name><name><surname>Bilder</surname> <given-names>D</given-names></name><name><surname>Brech</surname> <given-names>A</given-names></name><name><surname>Stenmark</surname> <given-names>H</given-names></name><name><surname>Rusten</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Microenvironmental autophagy promotes tumour growth</article-title><source>Nature</source><volume>541</volume><fpage>417</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nature20815</pub-id><pub-id pub-id-type="pmid">28077876</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kondo</surname> <given-names>S</given-names></name><name><surname>Senoo-Matsuda</surname> <given-names>N</given-names></name><name><surname>Hiromi</surname> <given-names>Y</given-names></name><name><surname>Miura</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>DRONC coordinates cell death and compensatory proliferation</article-title><source>Molecular and Cellular Biology</source><volume>26</volume><fpage>7258</fpage><lpage>7268</lpage><pub-id pub-id-type="doi">10.1128/MCB.00183-06</pub-id><pub-id pub-id-type="pmid">16980627</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurada</surname> <given-names>P</given-names></name><name><surname>White</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Ras promotes cell survival in Drosophila by downregulating hid expression</article-title><source>Cell</source><volume>95</volume><fpage>319</fpage><lpage>329</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)81764-X</pub-id><pub-id pub-id-type="pmid">9814703</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtova</surname> <given-names>AV</given-names></name><name><surname>Xiao</surname> <given-names>J</given-names></name><name><surname>Mo</surname> <given-names>Q</given-names></name><name><surname>Pazhanisamy</surname> <given-names>S</given-names></name><name><surname>Krasnow</surname> <given-names>R</given-names></name><name><surname>Lerner</surname> <given-names>SP</given-names></name><name><surname>Chen</surname> <given-names>F</given-names></name><name><surname>Roh</surname> <given-names>TT</given-names></name><name><surname>Lay</surname> <given-names>E</given-names></name><name><surname>Ho</surname> <given-names>PL</given-names></name><name><surname>Chan</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance</article-title><source>Nature</source><volume>517</volume><fpage>209</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nature14034</pub-id><pub-id pub-id-type="pmid">25470039</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurucz</surname> <given-names>E</given-names></name><name><surname>Váczi</surname> <given-names>B</given-names></name><name><surname>Márkus</surname> <given-names>R</given-names></name><name><surname>Laurinyecz</surname> <given-names>B</given-names></name><name><surname>Vilmos</surname> <given-names>P</given-names></name><name><surname>Zsámboki</surname> <given-names>J</given-names></name><name><surname>Csorba</surname> <given-names>K</given-names></name><name><surname>Gateff</surname> <given-names>E</given-names></name><name><surname>Hultmark</surname> <given-names>D</given-names></name><name><surname>Andó</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Definition of Drosophila hemocyte subsets by cell-type specific antigens</article-title><source>Acta Biologica Hungarica</source><volume>58</volume><fpage>95</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1556/ABiol.58.2007.Suppl.8</pub-id><pub-id pub-id-type="pmid">18297797</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Külshammer</surname> <given-names>E</given-names></name><name><surname>Uhlirova</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The actin cross-linker Filamin/Cheerio mediates tumor malignancy downstream of JNK signaling</article-title><source>Journal of Cell Science</source><volume>126</volume><fpage>927</fpage><lpage>938</lpage><pub-id pub-id-type="doi">10.1242/jcs.114462</pub-id><pub-id pub-id-type="pmid">23239028</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Külshammer</surname> <given-names>E</given-names></name><name><surname>Mundorf</surname> <given-names>J</given-names></name><name><surname>Kilinc</surname> <given-names>M</given-names></name><name><surname>Frommolt</surname> <given-names>P</given-names></name><name><surname>Wagle</surname> <given-names>P</given-names></name><name><surname>Uhlirova</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Interplay among Drosophila transcription factors Ets21c, Fos and Ftz-F1 drives JNK-mediated tumor malignancy</article-title><source>Disease Models &amp; Mechanisms</source><volume>8</volume><fpage>1279</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1242/dmm.020719</pub-id><pub-id pub-id-type="pmid">26398940</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>T</given-names></name><name><surname>Luo</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis</article-title><source>Neuron</source><volume>22</volume><fpage>451</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80701-1</pub-id><pub-id pub-id-type="pmid">10197526</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leong</surname> <given-names>GR</given-names></name><name><surname>Goulding</surname> <given-names>KR</given-names></name><name><surname>Amin</surname> <given-names>N</given-names></name><name><surname>Richardson</surname> <given-names>HE</given-names></name><name><surname>Brumby</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Scribble mutants promote aPKC and JNK-dependent epithelial neoplasia independently of Crumbs</article-title><source>BMC Biology</source><volume>7</volume><elocation-id>62</elocation-id><pub-id pub-id-type="doi">10.1186/1741-7007-7-62</pub-id><pub-id pub-id-type="pmid">19778415</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leulier</surname> <given-names>F</given-names></name><name><surname>Ribeiro</surname> <given-names>PS</given-names></name><name><surname>Palmer</surname> <given-names>E</given-names></name><name><surname>Tenev</surname> <given-names>T</given-names></name><name><surname>Takahashi</surname> <given-names>K</given-names></name><name><surname>Robertson</surname> <given-names>D</given-names></name><name><surname>Zachariou</surname> <given-names>A</given-names></name><name><surname>Pichaud</surname> <given-names>F</given-names></name><name><surname>Ueda</surname> <given-names>R</given-names></name><name><surname>Meier</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Systematic in vivo RNAi analysis of putative components of the Drosophila cell death machinery</article-title><source>Cell Death and Differentiation</source><volume>13</volume><fpage>1663</fpage><lpage>1674</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401868</pub-id><pub-id pub-id-type="pmid">16485033</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>F</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Peng</surname> <given-names>Y</given-names></name><name><surname>Roop</surname> <given-names>DR</given-names></name><name><surname>Bedford</surname> <given-names>JS</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Apoptotic cells activate the &quot;phoenix rising&quot; pathway to promote wound healing and tissue regeneration</article-title><source>Science Signaling</source><volume>3</volume><elocation-id>ra13</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000634</pub-id><pub-id pub-id-type="pmid">20179271</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manent</surname> <given-names>J</given-names></name><name><surname>Banerjee</surname> <given-names>S</given-names></name><name><surname>de Matos Simoes</surname> <given-names>R</given-names></name><name><surname>Zoranovic</surname> <given-names>T</given-names></name><name><surname>Mitsiades</surname> <given-names>C</given-names></name><name><surname>Penninger</surname> <given-names>JM</given-names></name><name><surname>Simpson</surname> <given-names>KJ</given-names></name><name><surname>Humbert</surname> <given-names>PO</given-names></name><name><surname>Richardson</surname> <given-names>HE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Autophagy suppresses Ras-driven epithelial tumourigenesis by limiting the accumulation of reactive oxygen species</article-title><source>Oncogene</source><pub-id pub-id-type="doi">10.1038/onc.2017.175</pub-id><pub-id pub-id-type="pmid">28581519</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin-Belmonte</surname> <given-names>F</given-names></name><name><surname>Perez-Moreno</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Epithelial cell polarity, stem cells and cancer</article-title><source>Nature Reviews Cancer</source><volume>12</volume><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/nrc3169</pub-id><pub-id pub-id-type="pmid">22169974</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martín</surname> <given-names>FA</given-names></name><name><surname>Peréz-Garijo</surname> <given-names>A</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Apoptosis in Drosophila: compensatory proliferation and undead cells</article-title><source>The International Journal of Developmental Biology</source><volume>53</volume><fpage>1341</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1387/ijdb.072447fm</pub-id><pub-id pub-id-type="pmid">19247932</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname> <given-names>P</given-names></name><name><surname>Silke</surname> <given-names>J</given-names></name><name><surname>Leevers</surname> <given-names>SJ</given-names></name><name><surname>Evan</surname> <given-names>GI</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>The Drosophila caspase DRONC is regulated by DIAP1</article-title><source>The EMBO Journal</source><volume>19</volume><fpage>598</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1093/emboj/19.4.598</pub-id><pub-id pub-id-type="pmid">10675329</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menéndez</surname> <given-names>J</given-names></name><name><surname>Pérez-Garijo</surname> <given-names>A</given-names></name><name><surname>Calleja</surname> <given-names>M</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway</article-title><source>Proceedings of the National Academy of Sciences</source><volume>107</volume><fpage>14651</fpage><lpage>14656</lpage><pub-id pub-id-type="doi">10.1073/pnas.1009376107</pub-id><pub-id pub-id-type="pmid">20679206</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mollereau</surname> <given-names>B</given-names></name><name><surname>Perez-Garijo</surname> <given-names>A</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name><name><surname>Miura</surname> <given-names>M</given-names></name><name><surname>Gerlitz</surname> <given-names>O</given-names></name><name><surname>Ryoo</surname> <given-names>HD</given-names></name><name><surname>Steller</surname> <given-names>H</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Compensatory proliferation and apoptosis-induced proliferation: a need for clarification</article-title><source>Cell Death and Differentiation</source><volume>20</volume><fpage>181</fpage><pub-id pub-id-type="doi">10.1038/cdd.2012.82</pub-id><pub-id pub-id-type="pmid">22722336</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreno</surname> <given-names>E</given-names></name><name><surname>Yan</surname> <given-names>M</given-names></name><name><surname>Basler</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily</article-title><source>Current Biology : CB</source><volume>12</volume><fpage>1263</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(02)00954-5</pub-id><pub-id pub-id-type="pmid">12176339</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>More alive than dead: non-apoptotic roles for caspases in neuronal development, plasticity and disease</article-title><source>Cell Death and Differentiation</source><volume>24</volume><fpage>1411</fpage><lpage>1421</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.64</pub-id><pub-id pub-id-type="pmid">28644437</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname> <given-names>YI</given-names></name><name><surname>Kuranaga</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Caspase-dependent non-apoptotic processes in development</article-title><source>Cell Death and Differentiation</source><volume>24</volume><fpage>1422</fpage><lpage>1430</lpage><pub-id pub-id-type="doi">10.1038/cdd.2017.36</pub-id><pub-id pub-id-type="pmid">28524858</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newsome</surname> <given-names>TP</given-names></name><name><surname>Asling</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>BJ</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Analysis of Drosophila photoreceptor axon guidance in eye-specific mosaics</article-title><source>Development</source><volume>127</volume><fpage>851</fpage><lpage>860</lpage><pub-id pub-id-type="pmid">10648243</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohsawa</surname> <given-names>S</given-names></name><name><surname>Sugimura</surname> <given-names>K</given-names></name><name><surname>Takino</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name><name><surname>Miyawaki</surname> <given-names>A</given-names></name><name><surname>Igaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Elimination of oncogenic neighbors by JNK-mediated engulfment in Drosophila</article-title><source>Developmental Cell</source><volume>20</volume><fpage>315</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.02.007</pub-id><pub-id pub-id-type="pmid">21397843</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Owusu-Ansah</surname> <given-names>E</given-names></name><name><surname>Yavari</surname> <given-names>A</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A protocol for in vivo detection of reactive oxygen species</article-title><source>Protocol Exchange</source><pub-id pub-id-type="doi">10.1038/nprot.2008.23</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pagliarini</surname> <given-names>RA</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A genetic screen in Drosophila for metastatic behavior</article-title><source>Science</source><volume>302</volume><fpage>1227</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1126/science.1088474</pub-id><pub-id pub-id-type="pmid">14551319</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parisi</surname> <given-names>F</given-names></name><name><surname>Stefanatos</surname> <given-names>RK</given-names></name><name><surname>Strathdee</surname> <given-names>K</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Vidal</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Transformed epithelia trigger non-tissue-autonomous tumor suppressor response by adipocytes via activation of Toll and Eiger/TNF signaling</article-title><source>Cell Reports</source><volume>6</volume><fpage>855</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.01.039</pub-id><pub-id pub-id-type="pmid">24582964</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastor-Pareja</surname> <given-names>JC</given-names></name><name><surname>Wu</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>An innate immune response of blood cells to tumors and tissue damage in Drosophila</article-title><source>Disease Models and Mechanisms</source><volume>1</volume><fpage>144</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1242/dmm.000950</pub-id><pub-id pub-id-type="pmid">19048077</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez</surname> <given-names>E</given-names></name><name><surname>Das</surname> <given-names>G</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name><name><surname>Baehrecke</surname> <given-names>EH</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Autophagy regulates tissue overgrowth in a context-dependent manner</article-title><source>Oncogene</source><volume>34</volume><fpage>3369</fpage><lpage>3376</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.285</pub-id><pub-id pub-id-type="pmid">25174403</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Garijo</surname> <given-names>A</given-names></name><name><surname>Martín</surname> <given-names>FA</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Caspase inhibition during apoptosis causes abnormal signalling and developmental aberrations in Drosophila</article-title><source>Development</source><volume>131</volume><fpage>5591</fpage><lpage>5598</lpage><pub-id pub-id-type="doi">10.1242/dev.01432</pub-id><pub-id pub-id-type="pmid">15496444</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Garijo</surname> <given-names>A</given-names></name><name><surname>Martín</surname> <given-names>FA</given-names></name><name><surname>Struhl</surname> <given-names>G</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Dpp signaling and the induction of neoplastic tumors by caspase-inhibited apoptotic cells in Drosophila</article-title><source>Proceedings of the National Academy of Sciences</source><volume>102</volume><fpage>17664</fpage><lpage>17669</lpage><pub-id pub-id-type="doi">10.1073/pnas.0508966102</pub-id><pub-id pub-id-type="pmid">16314564</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pérez-Garijo</surname> <given-names>A</given-names></name><name><surname>Shlevkov</surname> <given-names>E</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The role of Dpp and Wg in compensatory proliferation and in the formation of hyperplastic overgrowths caused by apoptotic cells in the Drosophila wing disc</article-title><source>Development</source><volume>136</volume><fpage>1169</fpage><lpage>1177</lpage><pub-id pub-id-type="doi">10.1242/dev.034017</pub-id><pub-id pub-id-type="pmid">19244279</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudrapatna</surname> <given-names>VA</given-names></name><name><surname>Bangi</surname> <given-names>E</given-names></name><name><surname>Cagan</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Caspase signalling in the absence of apoptosis drives Jnk-dependent invasion</article-title><source>EMBO Reports</source><volume>14</volume><fpage>172</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1038/embor.2012.217</pub-id><pub-id pub-id-type="pmid">23306653</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryoo</surname> <given-names>HD</given-names></name><name><surname>Gorenc</surname> <given-names>T</given-names></name><name><surname>Steller</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Apoptotic cells can induce compensatory cell proliferation through the JNK and the Wingless signaling pathways</article-title><source>Developmental Cell</source><volume>7</volume><fpage>491</fpage><lpage>501</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.08.019</pub-id><pub-id pub-id-type="pmid">15469838</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryoo</surname> <given-names>HD</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The role of apoptosis-induced proliferation for regeneration and cancer</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a008797</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a008797</pub-id><pub-id pub-id-type="pmid">22855725</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvesen</surname> <given-names>GS</given-names></name><name><surname>Hempel</surname> <given-names>A</given-names></name><name><surname>Coll</surname> <given-names>NS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Protease signaling in animal and plant-regulated cell death</article-title><source>The FEBS Journal</source><volume>283</volume><fpage>2577</fpage><lpage>2598</lpage><pub-id pub-id-type="doi">10.1111/febs.13616</pub-id><pub-id pub-id-type="pmid">26648190</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santabárbara-Ruiz</surname> <given-names>P</given-names></name><name><surname>López-Santillán</surname> <given-names>M</given-names></name><name><surname>Martínez-Rodríguez</surname> <given-names>I</given-names></name><name><surname>Binagui-Casas</surname> <given-names>A</given-names></name><name><surname>Pérez</surname> <given-names>L</given-names></name><name><surname>Milán</surname> <given-names>M</given-names></name><name><surname>Corominas</surname> <given-names>M</given-names></name><name><surname>Serras</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>ROS-Induced JNK and p38 Signaling Is Required for Unpaired Cytokine Activation during Drosophila Regeneration</article-title><source>PLOS Genetics</source><volume>11</volume><elocation-id>e1005595</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1005595</pub-id><pub-id pub-id-type="pmid">26496642</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafique</surname> <given-names>E</given-names></name><name><surname>Torina</surname> <given-names>A</given-names></name><name><surname>Reichert</surname> <given-names>K</given-names></name><name><surname>Colantuono</surname> <given-names>B</given-names></name><name><surname>Nur</surname> <given-names>N</given-names></name><name><surname>Zeeshan</surname> <given-names>K</given-names></name><name><surname>Ravichandran</surname> <given-names>V</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Feng</surname> <given-names>J</given-names></name><name><surname>Zeeshan</surname> <given-names>K</given-names></name><name><surname>Benjamin</surname> <given-names>LE</given-names></name><name><surname>Irani</surname> <given-names>K</given-names></name><name><surname>Harrington</surname> <given-names>EO</given-names></name><name><surname>Sellke</surname> <given-names>FW</given-names></name><name><surname>Abid</surname> <given-names>MR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mitochondrial redox plays a critical role in the paradoxical effects of NAPDH oxidase-derived ROS on coronary endothelium</article-title><source>Cardiovascular Research</source><volume>113</volume><fpage>234</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1093/cvr/cvw249</pub-id><pub-id pub-id-type="pmid">28088753</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shalini</surname> <given-names>S</given-names></name><name><surname>Dorstyn</surname> <given-names>L</given-names></name><name><surname>Dawar</surname> <given-names>S</given-names></name><name><surname>Kumar</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Old, new and emerging functions of caspases</article-title><source>Cell Death and Differentiation</source><volume>22</volume><fpage>526</fpage><lpage>539</lpage><pub-id pub-id-type="doi">10.1038/cdd.2014.216</pub-id><pub-id pub-id-type="pmid">25526085</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shlevkov</surname> <given-names>E</given-names></name><name><surname>Morata</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A dp53/JNK-dependant feedback amplification loop is essential for the apoptotic response to stress in Drosophila</article-title><source>Cell Death and Differentiation</source><volume>19</volume><fpage>451</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1038/cdd.2011.113</pub-id><pub-id pub-id-type="pmid">21886179</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname> <given-names>A</given-names></name><name><surname>Roth</surname> <given-names>KA</given-names></name><name><surname>Sayers</surname> <given-names>RO</given-names></name><name><surname>Shindler</surname> <given-names>KS</given-names></name><name><surname>Wong</surname> <given-names>AM</given-names></name><name><surname>Fritz</surname> <given-names>LC</given-names></name><name><surname>Tomaselli</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system</article-title><source>Cell Death and Differentiation</source><volume>5</volume><fpage>1004</fpage><lpage>1016</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400449</pub-id><pub-id pub-id-type="pmid">9894607</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname> <given-names>AS</given-names></name><name><surname>Adams</surname> <given-names>DS</given-names></name><name><surname>Qiu</surname> <given-names>D</given-names></name><name><surname>Koustubhan</surname> <given-names>P</given-names></name><name><surname>Levin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Apoptosis is required during early stages of tail regeneration in Xenopus laevis</article-title><source>Developmental Biology</source><volume>301</volume><fpage>62</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2006.10.048</pub-id><pub-id pub-id-type="pmid">17150209</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlirova</surname> <given-names>M</given-names></name><name><surname>Jasper</surname> <given-names>H</given-names></name><name><surname>Bohmann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Non-cell-autonomous induction of tissue overgrowth by JNK/Ras cooperation in a Drosophila tumor model</article-title><source>Proceedings of the National Academy of Sciences</source><volume>102</volume><fpage>13123</fpage><lpage>13128</lpage><pub-id pub-id-type="doi">10.1073/pnas.0504170102</pub-id><pub-id pub-id-type="pmid">16150723</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlirova</surname> <given-names>M</given-names></name><name><surname>Bohmann</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila</article-title><source>The EMBO Journal</source><volume>25</volume><fpage>5294</fpage><lpage>5304</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601401</pub-id><pub-id pub-id-type="pmid">17082773</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaughen</surname> <given-names>J</given-names></name><name><surname>Igaki</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Slit-Robo Repulsive Signaling Extrudes Tumorigenic Cells from Epithelia</article-title><source>Developmental Cell</source><volume>39</volume><fpage>683</fpage><lpage>695</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2016.11.015</pub-id><pub-id pub-id-type="pmid">27997825</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>CW</given-names></name><name><surname>Purkayastha</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>KT</given-names></name><name><surname>Thaker</surname> <given-names>SK</given-names></name><name><surname>Banerjee</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>In vivo</italic> genetic dissection of tumor growth and the Warburg effect</article-title><source>eLife</source><volume>5</volume><elocation-id>e18126</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.18126</pub-id><pub-id pub-id-type="pmid">27585295</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wells</surname> <given-names>BS</given-names></name><name><surname>Yoshida</surname> <given-names>E</given-names></name><name><surname>Johnston</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity</article-title><source>Current Biology</source><volume>16</volume><fpage>1606</fpage><lpage>1615</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2006.07.046</pub-id><pub-id pub-id-type="pmid">16920621</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wodarz</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tumor suppressors: linking cell polarity and growth control</article-title><source>Current Biology</source><volume>10</volume><fpage>R624</fpage><lpage>R626</lpage><pub-id pub-id-type="doi">10.1016/S0960-9822(00)00658-8</pub-id><pub-id pub-id-type="pmid">10996086</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>T</given-names></name><name><surname>Rubin</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Analysis of genetic mosaics in developing and adult Drosophila tissues</article-title><source>Development</source><volume>117</volume><fpage>1223</fpage><lpage>1237</lpage><pub-id pub-id-type="pmid">8404527</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>D</given-names></name><name><surname>Woodfield</surname> <given-names>SE</given-names></name><name><surname>Lee</surname> <given-names>TV</given-names></name><name><surname>Fan</surname> <given-names>Y</given-names></name><name><surname>Antonio</surname> <given-names>C</given-names></name><name><surname>Bergmann</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Genetic control of programmed cell death (apoptosis) in Drosophila</article-title><source>Fly</source><volume>3</volume><fpage>78</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.4161/fly.3.1.7800</pub-id><pub-id pub-id-type="pmid">19182545</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Feng</surname> <given-names>X</given-names></name><name><surname>Cheng</surname> <given-names>J</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Gong</surname> <given-names>Y</given-names></name><name><surname>Zhu</surname> <given-names>Y</given-names></name><name><surname>Li</surname> <given-names>C</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name><name><surname>Huang</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Increased HMGB1 and cleaved caspase-3 stimulate the proliferation of tumor cells and are correlated with the poor prognosis in colorectal cancer</article-title><source>Journal of Experimental &amp; Clinical Cancer Research</source><volume>34</volume><fpage>51</fpage><pub-id pub-id-type="doi">10.1186/s13046-015-0166-1</pub-id><pub-id pub-id-type="pmid">25986235</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.26747.014</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>McNeill</surname><given-names>Helen</given-names></name><role>Reviewing Editor</role><aff><institution>University of Toronto</institution><country>Canada</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Tumor-promoting function of apoptotic caspases by an amplification loop involving ROS, macrophages and <italic>JNK</italic> in <italic>Drosophila</italic>&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by K VijayRaghavan as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Pascal Meier</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>While caspases and cell death are generally thought to play tumour suppressive roles, more and more evidence from <italic>Drosophila</italic> and mammals indicate that caspases in fact can have tumour promoting roles. Here, Bergmann and co-workers use a <italic>Drosophila</italic> Scribble (Scrib)/<italic>Ras</italic>-<sup>V12</sup> tumour model to assess the contribution of caspases. They find that the effector caspases contribute to tumour growth. In particular, they find that active <italic>drICE</italic> contributes to the production of intra- and extra-cellular ROS. The produced ROS in turn attracts hemocytes (<italic>Drosophila</italic> immune cells), which drive Eiger-dependent and <italic>JNK</italic>-mediated tumour growth.</p><p>Essential revisions:</p><p>The authors must quantify the data in the manuscript (as detailed below), as well as provide additional background information, and soften some conclusions or provide more support for these statements.</p><p>1) Several points are vague and often lacks needed quantification. For example when examining DHE staining of <italic>scrib-/- ras<sup>V12</sup></italic> clones, they comment that some clones have diffuse cytosolic staining, others stain intensely, while others have web-like staining. No attempt is made to define these differences. The DHE staining must be quantified. Other readouts of ROS could be useful. Similarly, when examining ROS and <italic>JNK</italic>, in <italic>scrib-/ ras<sup>V12</sup></italic> clones the authors state that &quot;many clones&quot; that were depleted of ROS or had inhibited caspase had less <italic>JNK</italic>. How many and what percent of clones lose <italic>JNK</italic>? How many (and what percent) of ey&gt;MARCM <italic>scrib-/-; ras<sup>v12</sup></italic> adult animals live when ROS is inhibited ?</p><p>Quantification of hemocyte numbers/area they cover relative to the total area of the clones is also needed for <xref ref-type="fig" rid="fig4">Figure 4</xref>. The number of hemocytes seems very different from <xref ref-type="fig" rid="fig4">Figures 4C-J</xref> to <xref ref-type="fig" rid="fig4">Figures 4K-Q</xref></p><p>2) The authors observe Cc3 and TUNEL staining inside and outside of <italic>scrib-/- ras<sup>v12</sup></italic> clones. The authors suggest that this death is essential to the tumor, and that the clones are supercompetitors. If they want to support this claim, they should inhibit death only in the surrounding wildtype cells and see if this is essential. Alternatively they can modify this in the Discussion.</p><p>3) Introduction: At present, the link to mammalian settings is insufficient, and the manuscript would benefit from more clearly spelling out previous observations hinting at a pro-tumorigenic role of caspases. Given the numerous studies that demonstrate tumor promoting roles of caspases, it might be appropriate to better reflect the current state of knowledge on this issue.</p><p>4)The authors suggest that cell death of non-<italic>Scrib/Ras<sup>V12</sup></italic> cells contribute to the growth of <italic>Scrib/Ras<sup>V12</sup></italic> tumor cells. It would be interesting to test this hypothesis, and evaluate the contribution of <italic>JNK</italic> activation and cell death of neighbouring wild-type cells (inactivating caspases only in wild-type cells). Although this would be interesting to address, I realize that by-stander cell death is not exactly to the issue of this manuscript. Hence, this could be an added benefit, but is non-essential for the current study.</p><p>5) <xref ref-type="fig" rid="fig3">Figure 3</xref> would profit from a side-by-side comparison with <italic>Scrib</italic> and <italic>Scrib/Ras<sup>V12</sup>/drICE</italic> RNAi. While the results from the TUNEL staining are clear and convincing, it is somewhat difficult to evaluate the extent of caspase activation in <xref ref-type="fig" rid="fig3">Figure 3</xref>. Clearly, inhibition of caspase activation suppresses ROS production, hemocyte recruitment and tumour overgrowth. The phenotype is clear. But it is difficult to evaluate the extent of caspase activation in the <italic>Scrib/Ras<sup>V12</sup></italic> clones.</p><p>It is important to show double staining of CC3 (cleaved caspase3) and TUNEL in the <italic>scrib Ras<sup>V12</sup></italic> clones. CC3 staining outside the clones, as shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, looks different to the TUNEL staining in <xref ref-type="fig" rid="fig3">Figure 3C</xref>. Furthermore, staining with CC3 and TUNEL would be the way to show which cells are indeed activating caspases without undergoing cell death. CC3 staining should be performed in <italic>scrib Ras<sup>V12</sup></italic> Duoxi, hCatS, SOD1, SOD2, Catalase… to provide a stronger evidence for the loop. It would also be nice to have CC3 staining in p35, dronci and dricei as controls.</p><p>6) A very interesting observation is the fact that <italic>JNK</italic> is activated in the periphery of the <italic>scrib Ras<sup>V12</sup></italic> clones when ROS or caspases are inhibited. Unfortunately, only few not very clear examples are provided, and instead most of the times staining with MMP1 is shown, where this phenomenon can't be observed. pJNK staining (which would be a better readout for <italic>JNK</italic> staining) or alternatively puc-lacZ, should be shown for the rest of the genotypes, including the <italic>scrib Ras<sup>V12</sup></italic> alone, which is not shown in the paper. Again, it would also be nice to have this staining in the JNKDN experiment as a control.</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.26747.015</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>The authors must quantify the data in the manuscript (as detailed below), as well as provide additional background information, and soften some conclusions or provide more support for these statements.</p></disp-quote><p>As requested, we have quantified all data in the manuscript. We have provided additional background information in the Introduction and have softened controversial statements.</p><disp-quote content-type="editor-comment"><p>1) Several points are vague and often lacks needed quantification. For example when examining DHE staining of scrib-/- ras<sup>V12</sup> clones, they comment that some clones have diffuse cytosolic staining, others stain intensely, while others have web-like staining. No attempt is made to define these differences. The DHE staining must be quantified. Other readouts of ROS could be useful. Similarly, when examining ROS and JNK, in scrib-/ ras<sup>V12</sup> clones the authors state that &quot;many clones&quot; that were depleted of ROS or had inhibited caspase had less JNK. How many and what percent of clones lose JNK? How many (and what percent) of ey&gt;MARCM scrib-/-; ras<sup>v12</sup> adult animals live when ROS is inhibited ?</p><p>Quantification of hemocyte numbers/area they cover relative to the total area of the clones is also needed for <xref ref-type="fig" rid="fig4">Figure 4</xref>. The number of hemocytes seems very different from <xref ref-type="fig" rid="fig4">Figures 4C-J</xref> to <xref ref-type="fig" rid="fig4">Figures 4K-Q</xref></p></disp-quote><p>We agree with the reviewers that quantification is needed to support our conclusions. Therefore, we have spent a considerable amount of time to quantify all the data. This includes the DHE, pJNK, MMP1, hemocytes, cleaved caspase-3 and TUNEL labelings. We have also added and quantified H<sub>2</sub>DCF-DA labelings as additional ROS readout in <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>. The H<sub>2</sub>DCF-DA data are very consistent with the DHE labelings. We have also significantly expanded on the counts of pupal and adult survival and have now much more reliable numbers for all genotypes (<xref ref-type="fig" rid="fig1">Figures 1G</xref> and <xref ref-type="fig" rid="fig2">2N</xref>). Overall, the quantified data are very consistent with our conclusions.</p><p><xref ref-type="fig" rid="fig4">Figures 4K-Q</xref> are not concerned with the number of hemocytes, but rather with the morphology of hemocytes on <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> discs and discs that have reduced caspase activity and reduced ROS. We have clarified this point in the text.</p><disp-quote content-type="editor-comment"><p>2) The authors observe Cc3 and TUNEL staining inside and outside of scrib-/- ras<sup>v12</sup> clones. The authors suggest that this death is essential to the tumor, and that the clones are supercompetitors. If they want to support this claim, they should inhibit death only in the surrounding wildtype cells and see if this is essential. Alternatively they can modify this in the Discussion.</p></disp-quote><p>In the long term, it is certainly a very important question to address if the apoptotic cell death outside the clones (non-autonomously) is essential for tumor growth. However, experimentally, it is not possible to address the allotted time of the revision. We have therefore removed these statements and any reference to supercompetitors.</p><disp-quote content-type="editor-comment"><p>3) Introduction: At present, the link to mammalian settings is insufficient, and the manuscript would benefit from more clearly spelling out previous observations hinting at a pro-tumorigenic role of caspases. Given the numerous studies that demonstrate tumor promoting roles of caspases, it might be appropriate to better reflect the current state of knowledge on this issue.</p></disp-quote><p>We agree with the reviewers and have expanded and clarified the different forms of AiP and the role of caspases for tumor growth in mammals. We also have cited all relevant original papers on this topic.</p><disp-quote content-type="editor-comment"><p>4)The authors suggest that cell death of non-Scrib/Ras<sup>V12</sup> cells contribute to the growth of Scrib/Ras<sup>V12</sup> tumor cells. It would be interesting to test this hypothesis, and evaluate the contribution of JNK activation and cell death of neighbouring wild-type cells (inactivating caspases only in wild-type cells). Although this would be interesting to address, I realize that by-stander cell death is not exactly to the issue of this manuscript. Hence, this could be an added benefit, but is non-essential for the current study.</p></disp-quote><p>This point is similar to point #2. To inactivate caspases only in wild-type cells in a <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> mosaic background is experimentally quite challenging and not possible in the allocated time of the revision.</p><disp-quote content-type="editor-comment"><p>5) <xref ref-type="fig" rid="fig3">Figure 3</xref> would profit from a side-by-side comparison with Scrib and Scrib/Ras<sup>V12</sup>/drICE RNAi. While the results from the TUNEL staining are clear and convincing, it is somewhat difficult to evaluate the extent of caspase activation in <xref ref-type="fig" rid="fig3">Figure 3</xref>. Clearly, inhibition of caspase activation suppresses ROS production, hemocyte recruitment and tumour overgrowth. The phenotype is clear. But it is difficult to evaluate the extent of caspase activation in the Scrib/Ras<sup>V12</sup> clones.</p></disp-quote><p>We have added the <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup> /drICE</italic> RNAi analysis to <xref ref-type="fig" rid="fig3">Figure 3</xref>. We have omitted a <italic>scrib</italic> analysis, because <italic>scrib</italic> clones are very small. In order to address the extent of caspase activation in <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> clones, we have quantified the CC3 data inside and outside the clones (autonomously and non-autonomously) in control (wild-type mosaics), <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> and <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup> /drICE</italic> RNAi mosaics. We found that the caspase activity outside <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> clones is about 2.5 times higher than inside the clones. These data are presented in <xref ref-type="fig" rid="fig3">Figure 3D</xref>.</p><disp-quote content-type="editor-comment"><p>It is important to show double staining of CC3 (cleaved caspase3) and TUNEL in the scrib Ras<sup>V12</sup> clones. CC3 staining outside the clones, as shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>, looks different to the TUNEL staining in <xref ref-type="fig" rid="fig3">Figure 3C</xref>. Furthermore, staining with CC3 and TUNEL would be the way to show which cells are indeed activating caspases without undergoing cell death. CC3 staining should be performed in scrib Ras<sup>V12</sup> Duoxi, hCatS, SOD1, SOD2, Catalase… to provide a stronger evidence for the loop. It would also be nice to have CC3 staining in p35, dronci and dricei as controls.</p></disp-quote><p>We performed a large amount of CC3/TUNEL double labelings, but the CC3 signal in these double labelings was too weak to give meaningful and satisfying results. However, the TUNEL labelling in these experiments went very well which we were able to quantify. We found that almost 90% of all TUNEL-positive cells are outside (non-autonomous) of the <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> clones. The remaining TUNEL-positive cells are located inside these clones. Thus, although our CC3/TUNEL double labelings were inconclusive, these statistical data strongly confirm that most apoptotic cells are located outside of <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> cells.</p><p>The CC3 and TUNEL labelings outside the clones look different, because one stain is cytosolic (CC3), while the other one is nuclear (TUNEL). We have also added CC3 labelings of <italic>scrib<sup>-/-</sup> Ras<sup>V12</sup></italic> with Duox RNAi, hCatS, Catalase and SOD2 in the supplement to <xref ref-type="fig" rid="fig3">Figure 3</xref>. In all cases, the CC3 signal is strongly reduced, further strengthening the positive feedback amplification loop.</p><disp-quote content-type="editor-comment"><p>6) A very interesting observation is the fact that JNK is activated in the periphery of the scrib Ras<sup>V12</sup> clones when ROS or caspases are inhibited. Unfortunately, only few not very clear examples are provided, and instead most of the times staining with MMP1 is shown, where this phenomenon can't be observed. pJNK staining (which would be a better readout for JNK staining) or alternatively puc-lacZ, should be shown for the rest of the genotypes, including the scrib Ras<sup>V12</sup> alone, which is not shown in the paper. Again, it would also be nice to have this staining in the JNKDN experiment as a control.</p></disp-quote><p>We have replaced the MMP1 labelings in <xref ref-type="fig" rid="fig5">Figure 5</xref> with pJNK stainings and moved the MMP1 labelings as supporting information into the supplement. As requested, we have also added the JNKDN experiment as control. In addition, all data are quantified.</p></body></sub-article></article>